"VAR","Variable","UNIT","Measure","COU","Country","YEA","Year","Value","Flag Codes","Flags"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",113.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",118.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",124.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",125.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",132.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",133.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",132.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",138.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",142.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",144.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",145.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",151.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",153.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",151.2,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",153.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",152.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",150.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",150.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",151.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",142.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",115.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",116.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",119.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",121.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",148.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",145.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",128.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",135.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",143.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",144.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",68.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",78,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",83.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",91.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",100.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",102.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",104.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",113.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",131.5,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",141.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",148.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",153.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",159.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",165.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",170.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",177.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",189,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",174.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",181.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",187.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",98.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",103.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",105.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",107.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",111.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",112.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",114.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",117.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",119.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",208.8,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",209.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",214.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",220.2,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",213.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",226,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",212.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",206.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",195.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",213.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",201.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",231.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",223.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",223.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",234.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",239.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",245.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",254.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",258.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",279.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",283.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",290.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",304.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",301.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",101.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",108.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",113.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",116.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",122.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",126.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",132.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",138,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",144.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",149.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",154.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",157.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",163.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",165.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",169.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",174.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",178,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",180.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",181.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",183.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",316.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",320.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",317.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",322.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",326,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",345.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",312.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",293.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",300.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",295.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",302.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",304.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",298.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",295.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",297.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",296.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",297.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",292,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",293,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",150.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",149.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",154.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",158.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",129.3,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",138.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",141.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",157.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",170.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",177.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",183.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",190.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",217,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",221.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",227,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",228.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",232.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",227.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",228.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",230.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",175.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",179.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",197.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",219.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",236.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",168.2,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",175.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",186.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",185.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",188.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",190.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",203,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",240.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",238.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",242.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",256.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",261.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",257.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",267.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",170.5,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",165.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",181.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",200.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",214.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",221.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",234.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",247.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",256,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",269.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",271.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",280.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",295.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",373.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",106.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",101.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",104.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",106.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",109.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",111.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",113.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",128.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",121.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",136.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",146.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",133,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",137,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",144.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",146.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",155.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",164,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",170.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",174.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",178.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",186.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",166.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",172.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",177.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",179.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",271.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",285.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",183.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",181.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",182.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",178.6,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",263.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",288.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",278.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",240.6,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",245.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",330.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",422.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",370,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",217.5,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",219.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",223.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",256,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",190.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",206.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",202.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",142.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",165,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",210.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",249.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",303,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",360.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",396.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",415.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",453.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",465.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",460.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",432.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",437.7,"D; P","Difference in methodology; Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",471.6,"D; P","Difference in methodology; Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",135.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",142.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",151.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",139.1,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",155.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",163.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",177.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",188.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",196.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",220.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",231.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",233.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",255.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",272.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",289.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",305.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",319.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",319.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",326.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",206.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",218.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",233.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",246,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",265.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",264.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",264.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",274.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",275,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",269.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",257.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",252.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",256,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",257.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",264.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",270.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",279.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",289,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",275.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",263.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",269.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",171.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",175.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",181,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",176.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",174,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",172.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",171.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",182.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",187.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",193.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",180.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",175.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",184.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",196.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",203.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",211.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",222.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",221.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",228.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",242.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",265.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",307.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",313,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",307,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",282,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",247,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",246.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",240.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",253.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",268.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",282.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",305.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",300,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",283.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",321.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",335.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",356,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",271,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",275.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",269.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",299,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",164.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",170,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",188.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",202.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",216.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",228.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",231.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",235.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",238,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",231.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",230.8,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",235.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",271.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",283,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",301.1,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",312,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",316.8,"P","Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",232.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",239.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",247.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",256.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",265.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",265.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",261.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",261,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",259.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",256.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",247.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",244,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",243.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",248.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",252.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",259.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",263.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",265.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",268.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",275.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",277.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",118.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",125.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",147,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",170.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",185.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",199.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",224,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",286.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",332.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",340.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",387.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",392.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",150.1,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",149.9,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",153,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",164.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",175.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",187.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",196.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",206.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",219.3,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",226.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",232,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",235.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",241.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",110.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",118.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",138.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",144.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",166.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",105.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",108.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",133.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",141.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",204.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",168.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",146.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",140,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",132.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",146.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",139.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",150,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",129.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",130.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",115.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",115.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",122.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",135.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",143,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",151.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",160.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",166,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",169.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",173.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",176.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",184.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",110.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",148.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",158.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",198,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",181.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",173.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",172.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",178.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",102.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",111.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",118,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",121.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",123.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",141.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",177.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",184.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",188.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",198.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",210.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",221.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",233.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",249.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",1.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",7.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",7.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",7.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",7.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",7.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",7.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",7.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",7.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",7.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",7.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",8.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",8.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",7.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",2.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",2.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",2.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",2.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",1.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",1.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",1.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",0.3,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",5.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",5.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",4.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",4.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",4.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",1.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",1.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",1.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",1.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",1.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",0.1,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",2.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",3.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",3.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",4.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",5.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",0.8,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",1.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",1.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",1.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",1.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",2.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",1.9,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",2.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",3.7,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",3.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",4.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",4.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",4.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",3.1,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",3.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",3.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",3.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",1.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",1.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",1.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",0,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",3.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",2.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",2.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",1.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",0,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",4.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",3.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",3.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",2.9,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",2.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",2.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",2.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",2.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",2.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",2.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",2.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",2.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",2.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",0.9,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",0.9,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",1.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",0.6,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",1.2,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",1.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",1.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",1.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",0.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",44,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",48.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",53.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",55.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",59.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",60.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",61.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",64.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",67.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",68.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",68.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",71.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",73.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",76.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",77.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",77.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",78,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",77.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",75.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",68.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",66.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",67.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",68.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",68.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",66.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",45.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",35.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",33.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",32.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",17.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",25,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",29.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",37,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",45.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",47.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",47.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",54.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",67.3,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",75.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",79.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",83.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",87.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",91.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",95.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",100.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",108.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",92.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",97.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",100,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",33.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",36.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",37.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",38.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",39.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",40.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",42.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",46.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",48.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",78.7,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",77.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",77.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",78.7,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",16.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",19.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",21.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",24.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",28.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",34.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",32.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",41.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",41,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",46.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",51.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",55.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",58.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",60.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",65.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",69.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",73.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",74.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",75.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",79.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",20.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",23.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",25.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",26.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",28.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",31.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",34.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",38,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",42.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",46.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",51.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",55.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",58.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",60.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",63.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",66.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",68.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",68.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",17,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",20.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",24.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",28.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",27.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",29.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",34.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",39.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",44.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",48.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",52.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",57.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",60.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",63.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",66.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",65.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",65.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",66.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",67.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",31.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",37.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",42.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",44.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",48.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",53.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",56.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",61.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",62,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",66.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",18.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",22.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",25.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",29.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",32.5,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",38.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",43.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",53.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",61.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",66.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",69.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",75.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",81.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",85.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",90.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",93.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",94.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",88.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",85.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",84.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",26,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",29.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",33.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",39.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",47.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",57.8,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",57.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",62.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",72.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",74.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",75.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",83.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",26.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",30.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",34.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",40.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",43.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",48.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",54.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",50.3,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",54.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",57.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",61,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",65.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",57.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",62.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",67.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",69.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",71.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",76,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",79.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",95,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",36.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",42.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",44.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",47,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",49.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",51.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",53.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",68,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",58.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",73.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",80.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",76.3,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",79.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",84,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",86.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",91.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",98.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",102.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",106.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",109,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",114,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",72.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",78.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",82.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",84.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",87.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",77.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",77.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",77.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",78.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",78.9,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",33.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",32.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",34.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",37.8,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",39.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",45.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",46.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",41.8,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",43,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",46.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",61.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",29.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",35.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",43.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",47.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",52.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",58.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",60,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",60.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",65.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",70,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",72.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",77.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",80.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",82.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",85.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",89.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",90.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",87.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",87.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",87,"D; P","Difference in methodology; Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",85.5,"D; P","Difference in methodology; Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",40.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",43.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",47.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",50.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",53.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",56.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",64,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",71.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",78.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",88.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",99.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",94.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",104,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",110.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",117,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",124.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",125.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",126.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",128.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",102,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",21.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",23.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",25.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",26.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",28.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",30.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",33.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",36.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",39.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",42.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",47.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",50.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",53.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",56.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",59.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",62.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",65.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",67.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",70.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",72,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",24.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",27.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",31.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",36.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",42.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",47.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",53.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",62.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",68.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",76.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",73,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",73.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",78.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",90.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",92.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",94.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",96.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",92,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",93.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",102.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",104.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",10.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",24.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",20.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",16,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",15.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",17.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",19.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",23.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",26.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",30.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",32.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",35.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",34.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",40.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",45,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",45.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",46.4,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",46.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",47.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",53.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",33.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",39.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",44,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",50.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",61.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",65.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",80.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",89.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",100.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",109.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",116.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",120.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",120.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",121.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",125.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",124.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",125.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",123.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",125.3,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",127.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",127.7,"P","Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",28.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",31.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",32.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",34,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",37.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",40.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",43.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",46.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",51.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",55.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",59.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",63.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",67.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",70.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",73.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",76.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",79.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",80.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",79.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",82.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",83,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",38.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",37.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",45.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",50.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",53.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",53,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",54.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",59.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",59.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",66.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",75.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",76.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",46.9,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",47.2,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",52.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",58.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",65.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",71.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",77.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",84.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",93.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",98.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",103.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",106.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",109.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",50.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",58.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",63.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",62.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",73.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",42.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",52.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",54.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",52.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",79.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",10.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",11.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",11.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",12.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",13.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",15,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",17,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",19.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",22.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",22,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",23.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",26.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",30.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",33.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",38.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",42.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",46,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",47.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",51.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",55,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",59.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",52.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",62,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",64.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",65.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",65.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",65.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",66.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",38,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",43.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",48.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",49.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",49.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",57.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",58.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",58.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",58.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",62,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",65.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",67.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",70.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",72.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",46.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",49,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",50,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",49.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",52.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",52.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",53.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",56.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",57.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",57.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",59.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",60.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",57.5,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",56.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",57.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",57.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",56.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",38.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",37.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",39.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",40.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",39.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",38,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",37.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",47.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",47.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",41.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",43.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",44.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",46.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",47.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",47.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",49.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",50.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",55.9,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",58,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",60.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",61.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",63.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",65,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",66.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",68,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",70,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",71,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",72.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",75.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",51.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",53.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",54.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",55.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",57,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",57.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",58.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",58.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",58.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",84.2,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",86.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",89,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",92.2,"E; D","Estimated value; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",38.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",47.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",48.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",50,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",47.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",52.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",54.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",63.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",62.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",68.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",73.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",76.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",78.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",80.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",84.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",88.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",89,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",89.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",90.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",92.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",23.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",25,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",27.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",29.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",32.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",34.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",37.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",39.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",43.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",45.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",47.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",49.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",51.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",51.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",52.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",53.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",55.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",56.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",42.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",48.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",52.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",58,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",62.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",66.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",70.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",72.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",77.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",79.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",83.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",84.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",85,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",86,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",88.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",90.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",92.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",92.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",95.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",44.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",48.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",50.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",53.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",55.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",59.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",60.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",61.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",62.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",65.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",53,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",56.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",61.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",59,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",63.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",66,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",71.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",76.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",79.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",81.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",82.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",83.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",83.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",83.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",82.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",83.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",83.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",85.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",88.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",39.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",47,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",51.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",58.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",67.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",85,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",83.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",86.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",80.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",81.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",83.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",88.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",42.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",45.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",49.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",52.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",54.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",54.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",58.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",58.5,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",53,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",62.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",70.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",74.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",75.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",77.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",76.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",69.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",72.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",74.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",75.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",77,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",79.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",15.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",17.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",19.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",21.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",22.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",24,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",25.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",26,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",26.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",28.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",31.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",38.1,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",38.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",41.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",42.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",44.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",46.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",47.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",48,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",48.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",51.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",61.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",62.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",62.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",62.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",62.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",62.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",62.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",63.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",63.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",64.4,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",59.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",68.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",65.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",64.1,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",64.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",65.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",60.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",61.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",60.3,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",63.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",65.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",67.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",31,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",33.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",36.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",38.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",38.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",50,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",50.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",51.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",60.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",63.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",63.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",63.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",64.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",65.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",64.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",64.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",63.8,"D; P","Difference in methodology; Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",62.9,"D; P","Difference in methodology; Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",49.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",53.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",57.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",60.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",60.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",68.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",70.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",70.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",72.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",72.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",74.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",75.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",75,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",75.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",76.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",77.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",75.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",76.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",26.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",29.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",32.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",33.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",36.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",39.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",42.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",44,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",46.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",47.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",48.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",48.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",48.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",48.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",50.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",51.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",53,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",55.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",56.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",58.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",59.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",50.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",56.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",61.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",62.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",58.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",57.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",58.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",62.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",68.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",67.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",62.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",58.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",61,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",62.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",64.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",67.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",68.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",67.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",70.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",74,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",76.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",10.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",31.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",33.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",35,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",33.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",36.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",38,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",43.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",48.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",50,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",57.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",61.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",58,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",65.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",70.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",75.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",76.3,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",76,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",76.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",88.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",39.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",43.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",46,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",48.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",51.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",53.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",55.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",58.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",60.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",62,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",55.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",56,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",66.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",66.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",71.1,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",72.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",75.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",76.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",78.1,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",79.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",81,"P","Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",20.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",26.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",30.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",35,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",42.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",44.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",46.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",47.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",49.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",50.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",51.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",53,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",53.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",55.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",56.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",58.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",60.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",62.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",64.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",67.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",70.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",36.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",41,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",47.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",53.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",56.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",58.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",61.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",64.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",66.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",72.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",75.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",79.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",63.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",67,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",70.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",74.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",77.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",79.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",82.3,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",83.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",84.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",85.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",84.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",34,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",30.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",45.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",52.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",59.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",46.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",39.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",47.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",48,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",73.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",15.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",17,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",18.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",19.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",22.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",21.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",29.7,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",34,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",40.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",41.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",45.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",47.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",53.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",54.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",57.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",59.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",61.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",62.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",64.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",65,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",67,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",36.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",55.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",59.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",62.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",64.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",62.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",61.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",59.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",46,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",48.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",51.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",54.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",55.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",61,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",70.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",73.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",74.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",76.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",78.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",80.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",82.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",83.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",26,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",28.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",31.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",35.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",39.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",41.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",42.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",45.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",46.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",45.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",44.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",43.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",43.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",44.1,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",45,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",46.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",35.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",36.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",37.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",37.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",67.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",69.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",71.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",75.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",81.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",83,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",80.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",52.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",53.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",51.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",13.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",14.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",13.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",16,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",18.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",19.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",20.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",21.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",36.2,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",82,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",90.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",95.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",99,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",101.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",104.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",106.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",109.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",112.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",114.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",115.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",68.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",67.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",63.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",64.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",61.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",60.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",61.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",60.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",64.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",91.9,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",101.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",102.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",104.7,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",179.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",182.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",192,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",201.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",201.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",218.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",196.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",222.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",191.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",195.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",198.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",193.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",190,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",188,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",192.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",193.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",198.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",203,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",204.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",206.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",82.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",83.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",89.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",94.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",99.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",102.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",105.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",109.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",115.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",117.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",118.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",119.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",120.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",116.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",116.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",116.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",114.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",114.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",109.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",118.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",120.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",126.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",134.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",144.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",122.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",136.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",140.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",144.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",138.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",137.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",138.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",140.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",143.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",143.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",138.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",137.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",135.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",47.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",62.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",66.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",73.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",42.5,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",46.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",47.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",49.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",53,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",55.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",59.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",62.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",65.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",68.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",72.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",75.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",77.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",78.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",107.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",112.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",161.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",160.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",173.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",212.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",214.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",182.2,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",176.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",185.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",223.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",239.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",247.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",260.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",39.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",43.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",51,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",55,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",63.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",69,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",76.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",49.8,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",58,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",75.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",86,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",92.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",80.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",78,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",82.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",87.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",91.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",96.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",100.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",104.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",109.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",72.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",77.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",83.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",83.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",86.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",89.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",99.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",91.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",103.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",102.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",105.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",97.6,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",96.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",98.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",94.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",99.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",107,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",111.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",108.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",111.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",118.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",164.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",155.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",163.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",174.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",183.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",190.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",125.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",129.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",135.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",134.8,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",26.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",73.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",80.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",86.1,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",86.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",90.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",96.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",87.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",79.9,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",81.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",83.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",85.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",94.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",100.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",105.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",109.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",116.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",118.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",125.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",127.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",138.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",152.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",161,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",167.5,"D; P","Difference in methodology; Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",170.5,"D; P","Difference in methodology; Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",92.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",99.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",102.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",109.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",120.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",118.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",121.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",123.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",126.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",129.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",131.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",133,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",134.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",135.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",137.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",141.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",143.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",142,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",87.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",94.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",103.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",108.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",114.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",119.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",121.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",125.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",130.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",133.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",136.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",138.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",141.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",143.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",141.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",140,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",143.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",144.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",148.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",151.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",152.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",85.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",80.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",79.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",71,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",73.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",77,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",80.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",89.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",91.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",91.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",93.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",95.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",88.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",83.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",85.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",87.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",90.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",90.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",93.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",94.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",93.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",89.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",96,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",103.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",101,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",98,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",115.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",125.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",130.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",134.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",129.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",133.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",134.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",128.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",143.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",149.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",155.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",289,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",288,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",290,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",334.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",81.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",88.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",94.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",101.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",104.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",108.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",120.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",123.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",125.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",123.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",133.2,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",137.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",149.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",159.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",170.5,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",177,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",177.3,"P","Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",220.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",242.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",260.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",273.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",285.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",293.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",306.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",320,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",329.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",338.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",338.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",334,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",306.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",284.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",266.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",258.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",256.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",251.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",235,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",229.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",224.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",76.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",79.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",87.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",96.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",107.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",111.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",118,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",124.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",134.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",144.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",169.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",170.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",135.2,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",142,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",148,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",157,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",162,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",165.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",169,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",176.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",187.6,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",193.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",196.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",204.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",223.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",64.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",122.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",107.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",157,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",159.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",157.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",87.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",106.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",121.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",196.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",42.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",43.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",48.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",51.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",63.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",60.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",63.8,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",56,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",61.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",60.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",67.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",75,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",91.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",95.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",101,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",101.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",105.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",107.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",110.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",107.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",109.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",118.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",136.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",128.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",138.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",68.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",82.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",71,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",73,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",64.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",69.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",73.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",78.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",80.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",85,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",90,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",96.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",103.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",107.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",105,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",105.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",106.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",106.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",266.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",275.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",286.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",296.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",318.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",332,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",347.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",376.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",388.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",390.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",390.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",392.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",389.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",388.1,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",380.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",376.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",371.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",368.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",371.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",371.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",270.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",273.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",271.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",267.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",269.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",257.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",245.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",317.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",319.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",329.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",274.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",292.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",308.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",331.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",357.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",369.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",390.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",411.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",456,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",475.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",486.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",488.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",492.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",491.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",487.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",486.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",487,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",477.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",474.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",476.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",383.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",405.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",412.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",415.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",424.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",424.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",421.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",419.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",419.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",469,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",473.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",487.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",508.3,"E; D","Estimated value; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",298.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",332.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",358.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",389.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",408.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",473.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",455.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",539.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",506.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",544.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",582.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",581.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",588.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",587.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",600.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",607,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",612.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",614.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",604.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",617.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",242,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",256.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",275.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",301.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",332.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",362.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",396.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",430.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",466.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",488.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",512.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",521,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",532,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",540.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",546.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",553.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",550.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",551.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",276.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",300.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",322.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",351.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",382.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",408.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",430.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",459.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",488.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",510.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",530.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",530.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",539.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",548.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",552.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",556.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",554.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",567.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",590.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",347.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",388.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",406.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",441.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",418.5,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",458.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",489.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",529.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",571.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",612.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",635.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",648.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",659.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",668.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",683.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",688.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",695.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",695.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",719.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",754.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",302.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",348.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",396.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",418.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",455.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",430.8,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",411.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",420.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",443.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",448.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",453.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",471.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",390.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",410.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",446.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",477.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",518.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",555.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",612.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",696.1,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",705.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",686.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",690.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",710.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",703.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",713.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",718.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",723.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",721.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",722.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",724.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",726.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",754.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",235.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",259.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",277.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",307.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",326.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",348.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",366.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",381.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",397.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",366.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",351.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",363.6,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",364.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",372.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",367.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",373.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",376.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",376.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",380.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",381.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",388.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",476.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",480.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",484.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",484.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",479.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",485.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",484.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",487.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",493,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",497.3,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",204.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",210.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",204.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",208.5,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",211.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",217.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",212,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",212.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",208.9,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",213,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",218.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",221.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",297.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",313.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",325.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",343.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",316.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",334.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",344.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",353.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",355.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",352.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",347.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",343.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",336,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",322.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",316.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",311.9,"D; P","Difference in methodology; Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",310.2,"D; P","Difference in methodology; Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",271.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",290.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",321.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",349.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",327.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",351.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",374.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",391.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",398.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",410.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",421.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",432.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",435.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",437.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",438.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",441.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",447.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",450,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",453,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",247.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",270.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",293.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",306,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",315,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",335.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",353.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",372,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",391.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",401.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",408.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",408.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",410.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",413,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",414.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",417.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",421.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",424.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",432.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",446,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",459.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",232.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",250.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",259.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",273.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",300.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",324.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",352.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",381.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",401.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",411.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",408.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",388.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",399.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",396.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",392.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",389.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",390.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",385.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",390,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",410.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",422.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",291.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",332.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",375.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",381,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",388,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",428.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",454.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",510.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",544.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",584.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",608.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",626.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",605,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",683.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",683.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",680,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",551.7,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",543,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",534.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",597.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",305.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",315.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",337,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",354.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",373.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",389,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",401.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",408.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",401.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",390.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",417.4,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",423.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",431.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",434.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",444.6,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",448.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",451.6,"P","Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",242.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",259.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",280.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",312,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",333.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",352.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",375.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",402.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",425.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",442.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",450.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",456.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",460.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",472.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",479.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",490.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",500.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",509,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",519.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",536.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",554.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",123.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",134.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",151.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",162.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",163.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",158.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",160.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",165.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",167.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",176.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",187.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",195.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",461.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",489.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",507.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",520.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",520.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",528.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",533.5,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",536.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",536.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",537.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",543.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",200.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",356.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",300.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",522.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",464.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",441.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",379,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",360.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",476.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",576.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",136.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",159.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",182.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",203,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",250.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",264.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",258.1,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",292.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",337.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",324.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",351.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",358.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",399.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",402.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",408.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",416.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",411.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",418.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",429.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",429.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",450,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",253.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",334.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",330.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",336.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",325.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",317.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",316.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",311.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",451,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",483.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",512.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",541.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",545.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",571.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",537,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",549.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",549.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",553,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",556.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",557.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",555.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",558.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",7.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",6.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",6.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",5.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",5.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",4.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",4.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",4.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",3.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",3.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",0.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",7.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",6.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",5.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",3.6,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",1.6,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",1.1,"E; D","Estimated value; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",12.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",11,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",9.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",8.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",7.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",6.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",5.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",5.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",4.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",3.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",2.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",7.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",7.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",6.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",6.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",5.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",5.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",5.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",4.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",4.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",4.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",4.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",4.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",9.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",8.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",7.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",7.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",6.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",5.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",5.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",4.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",4.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",14.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",14.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",13.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",12.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",10.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",9.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",8.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",7.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",7.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",6.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",6.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",5.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",5.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",4.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",11.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",11.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",11.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",10.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",9.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",3.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",9.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",9.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",8.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",8.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",7.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",6.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",6.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",5.7,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",5.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",4.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",2.3,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",1.5,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",1.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",1.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",1.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",1.1,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",6.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",5.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",4.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",4.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",3.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",1.1,"D; P","Difference in methodology; Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",1,"D; P","Difference in methodology; Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",5.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",4.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",4.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",3.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",3.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",5.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",5.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",5.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",4.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",4.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",4.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",8.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",8.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",7.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",6.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",6.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",6.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",5.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",5.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",5.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",4.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",4.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",8.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",8.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",7.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",6.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",5.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",5.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",4.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",4.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",2.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",6.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",5.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",5.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",5.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",4.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",4.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",3.3,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",2.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",2,"P","Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",8.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",8.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",7.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",6.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",6.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",5.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",5.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",4.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",3.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",2.7,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",15.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",14.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",14.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",12.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",12.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",10.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",10.2,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",8.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",8.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",6.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",6.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",5.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",5.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",4.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",4.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",3.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",3.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",1.9,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",2.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",8.6,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",8.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",8.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",8.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",8.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",8.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",8.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",8.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",8.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",1.6,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",1.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",1.5,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",4.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",5.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",5.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",5.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",6.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",6.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",7.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",7.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",7.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",8.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",8.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",8.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",8.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",8.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",11.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",11.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",11.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",11.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",10.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",10.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",11.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",10.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",10.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",10.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",2.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",2.3,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",2.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",4.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",4.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",4.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",5.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",5.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",6.5,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",6.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",7.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",7.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",7.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",5.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",5.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",5.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",6.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",6.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",6.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",6.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",6.4,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",6.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",6.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",3.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",3.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",3.6,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",4.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",7.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",7.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",7.8,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",0.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",0.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",0.9,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",1.1,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",8.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",8.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",8.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",8.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",8.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",7.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",7.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",7.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",7.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",7.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",7.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",6.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",6.5,"D; P","Difference in methodology; Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",6.3,"D; P","Difference in methodology; Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",2.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",2.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",2.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",2.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",7.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",7.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",7.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",7.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",6.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",6.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",6.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",5.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",5.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",5.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",5.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",4.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",4.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",5.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",5.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",5.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",4.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",4.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",5.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",5.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",6.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",7.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",7.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",8.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",8.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",9.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",10,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",10.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",10.4,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",10.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",10.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",11.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",3.2,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",3.2,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",3.2,"P","Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",0.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",0.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",0.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",0.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",0.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",0.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",0.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",0.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",1.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",1.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",2.1,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",2,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",1.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",1.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",1.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",1.4,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",3.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",3.6,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",4.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",4.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",4.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",5.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",6.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",5.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",5.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",3.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",4.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",4.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",4.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",4.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",5.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",5.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",5.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",6.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",7.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",7.5,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",7.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",7.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",8.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",8.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",9.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",9.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",9.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",8.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",7.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",7.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",7.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",7.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",4.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",4.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",5.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",5.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",6.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",6.7,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",6.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",1.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",1.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",2.4,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",2.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",3.1,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",7.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",7.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",7.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",7.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",8.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",8.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",10,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",9.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",10.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",11.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",12.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",13.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",13.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",13.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",13.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",13.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",12.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",12.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",12,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",2.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",1.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",1.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",1.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",13,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",13.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",13.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",14,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",13.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",14,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",13.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",12.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",12.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",12.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",13.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",13.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",13.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",13.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",11.7,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",12.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",12.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",12.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",13,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",13.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",13.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",13.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",13.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",14,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",6.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",6.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",7.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",6.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",6.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",5.1,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",5.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",5.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",13.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",14.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",15.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",15.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",17.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",17.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",23.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",23.5,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",23.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",24.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",24.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",25.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",25.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",26.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",28.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",29.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",31,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",32.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",33.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",34.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",37.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",1.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",1.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",1.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",2.1,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",2.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",2.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",2.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",2.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",2.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",2.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",2.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",10,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",9.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",10.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",10.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",9.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",9.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",9.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",9.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",9.4,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",2.5,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",2,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",1.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",2.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",4.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",4.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",4.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",5.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",5.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",5.1,"D; P","Difference in methodology; Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",4.9,"D; P","Difference in methodology; Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",2.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",2.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",3.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",3.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",9.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",9.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",5.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",4.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",4.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",4.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",4.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",4.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",4.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",4.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",4.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",4.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",0.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",0.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",0.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",0.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",0.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",0.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",0.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",1.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",6.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",8.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",10,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",10.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",12.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",13.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",16.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",19.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",22.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",24.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",27,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",27.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",32.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",33.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",33.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",20.6,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",19.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",21.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",8.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",8.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",8.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",9.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",9.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",9.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",8.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",8.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",8.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",8.9,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",8.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",9.1,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",9.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",9.1,"P","Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",0.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",1.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",2.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",3.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",1.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",2.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",2.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",3.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",3.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",3.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",14.5,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",14.7,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",14.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",15.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",14.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",14,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",13.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",13.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",13.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",1.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",2.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",0.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",2.2,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",3.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",7.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",6.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",12.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",14,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",14.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",14.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",14.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",15,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",14.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",14.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",43,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",37.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",34.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",32.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",30.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",29.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",29.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",28.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",27.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",26.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",26.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",26.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",26.3,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",26.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",25.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",24.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",24.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",18.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",17.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",17.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",17.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",18.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",16.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",16.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",19.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",18.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",18.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",39.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",41.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",42,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",42.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",44,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",44.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",44.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",44.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",46.8,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",46.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",45.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",44,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",42,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",41.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",39.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",38.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",37.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",34.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",50.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",50.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",49.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",49.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",49.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",48,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",46.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",44.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",43.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",45.5,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",44.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",44.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",44.6,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",31,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",34,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",37.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",39.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",38.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",42.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",39.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",46.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",40.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",42.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",43.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",43.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",44.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",45.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",47.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",49,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",47.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",48.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",49.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",104.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",106.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",107,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",108.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",112,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",112.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",113.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",112.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",112.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",110.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",108.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",102.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",98.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",97,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",94,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",90.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",87.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",83.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",60.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",61.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",61.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",61.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",61.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",62.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",63.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",62.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",62.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",61.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",61.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",59.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",58.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",57.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",56.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",54.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",52.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",51.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",51.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",56.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",63.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",65.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",71.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",66.1,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",69.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",70.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",72.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",74.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",76.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",76.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",76.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",75.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",73.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",74.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",72.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",71.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",69.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",70.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",71.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",32.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",34,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",34.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",35.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",35.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",23.2,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",22.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",23.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",28.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",29.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",30,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",31.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",37.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",40.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",40.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",42.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",42.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",46.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",40.7,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",38.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",43,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",44.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",43,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",42.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",41.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",40.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",40.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",40.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",40.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",41.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",58.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",61.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",60.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",65,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",67.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",64.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",70,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",65.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",61.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",60.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",60.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",58.7,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",56.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",54.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",52.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",47.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",46.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",44.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",42.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",38.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",39.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",39.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",39.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",39,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",38.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",38.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",38.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",39.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",38.9,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",20.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",20.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",20.3,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",19,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",18.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",17.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",17.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",14.7,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",14.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",14.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",14.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",20.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",22.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",23.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",22.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",23.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",24.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",25.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",27,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",27.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",29.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",30.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",31.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",31.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",31.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",31.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",31.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",30.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",30,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",29.9,"D; P","Difference in methodology; Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",30.8,"D; P","Difference in methodology; Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",51.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",51.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",52.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",54.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",55.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",54.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",55,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",56.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",54.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",54,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",53.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",53.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",52.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",50.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",49.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",48.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",47.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",47.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",40.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",41.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",42.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",42.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",45.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",47.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",50.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",51.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",53.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",52.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",42.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",40.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",38.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",37,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",35.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",33.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",32,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",31.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",30.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",29.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",42.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",40.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",39,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",40.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",40.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",43.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",44.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",45.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",44.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",44.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",46.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",48.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",50.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",51.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",51.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",51.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",52.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",54.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",53.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",31.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",34,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",36.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",33,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",31.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",32.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",38.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",39.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",40.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",41,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",39.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",39.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",37.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",43.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",44.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",45.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",43.1,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",42.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",44,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",50,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",32.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",34.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",35.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",36.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",38.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",38.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",40.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",41.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",41.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",44.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",44.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",44.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",42.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",41.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",43.6,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",43.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",43.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",43.7,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",43.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",43,"P","Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",73.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",77.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",77.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",78.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",81.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",83.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",86.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",90.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",89.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",87.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",84.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",81.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",77.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",74.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",70.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",67.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",65,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",61.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",59.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",57.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",56.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",6.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",6.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",6.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",6.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",6.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",7.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",7.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",7.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",8.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",9.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",9.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",74.8,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",73.1,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",70.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",69.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",67.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",65.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",63.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",61.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",60.3,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",58.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",55.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",53,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",50.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",54.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",68.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",53,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",102.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",75,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",80.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",72.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",44.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",69.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",83,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",16.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",16.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",17.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",18.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",20.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",20.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",21.6,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",21.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",23.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",21,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",21.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",21.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",22.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",23.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",24.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",25,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",24.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",24.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",26.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",26.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",27.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",14.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",20.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",20.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",18.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",18,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",17.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",33,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",34.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",34.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",35.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",34.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",35.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",35.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",35.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",35.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",35.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",35,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",35.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",21.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",22.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",23,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",23.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",24.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",25.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",25.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",26.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",26.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",25.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",25.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",26.4,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",26.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",25.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",25.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",37.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",36.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",34.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",28.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",29.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",27.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",27.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",33.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",31.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",31.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",58.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",61.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",62.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",64.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",67,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",67.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",69.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",71.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",75.7,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",76.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",78.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",78.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",78.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",78,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",77.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",76.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",75.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",73.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",71.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",70.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",27.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",27.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",27.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",26.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",26.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",26.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",26.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",25.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",27.1,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",26.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",26.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",26.4,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",52.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",59.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",63.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",68.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",69,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",76.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",71,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",80.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",68.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",69.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",70.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",68.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",66.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",65.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",64.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",65.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",64.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",65,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",61.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",60.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",20.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",22.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",24.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",27.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",30.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",32.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",33.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",34.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",35.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",35.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",35.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",35.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",35.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",35.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",35.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",34.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",57.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",61.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",63.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",65.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",68.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",68.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",69.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",70.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",70.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",70.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",71,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",70.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",70.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",70.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",69.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",67.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",64.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",63.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",63.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",47,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",50.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",52.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",51.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",52.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",55.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",55.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",53.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",55.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",56.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",49.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",56.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",61.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",69.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",67.8,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",73.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",77.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",81.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",83.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",87.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",89.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",89.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",89.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",89,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",88.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",87.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",85.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",83.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",82.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",82.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",21.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",24,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",26.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",28.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",30.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",44.1,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",43,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",45.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",50.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",52.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",55.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",41.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",43.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",48.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",50.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",52.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",53.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",58.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",54.6,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",49.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",51.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",55.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",59.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",61.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",63.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",66.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",68.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",69.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",71.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",72.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",72.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",75.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",40.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",42.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",42.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",45.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",46.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",47.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",47.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",44.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",44.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",41.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",42.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",42.8,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",41.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",40.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",39,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",38.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",36.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",35.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",45.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",46.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",47.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",48.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",48.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",49.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",50.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",51.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",51.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",52.3,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",14.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",14.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",14.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",14.9,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",14.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",12.7,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",12.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",13,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",13,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",33.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",34.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",35.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",33.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",35.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",37.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",37.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",35.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",38.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",40.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",39.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",39.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",39.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",39.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",39.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",37.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",38.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",37.5,"D; P","Difference in methodology; Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",38.5,"D; P","Difference in methodology; Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",41.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",43.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",46.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",47.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",49.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",51.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",53.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",53.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",51.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",50.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",48.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",47.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",46.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",44.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",43.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",33.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",35.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",38.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",38.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",39.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",40.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",40.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",41.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",41.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",40.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",40.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",39.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",38.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",37.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",36.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",35.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",34.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",34.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",33.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",33,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",13.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",15,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",16.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",18.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",19.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",21.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",24.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",23.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",25.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",27.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",29,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",28.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",31.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",32.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",33.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",34.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",36.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",38,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",39.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",29.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",35,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",38.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",42,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",42.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",46.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",45.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",47.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",49.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",51,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",56.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",57.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",57.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",67.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",71,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",73.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",64,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",64.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",65.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",73.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",14.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",15.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",16.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",17,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",18.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",18.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",19.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",20.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",20.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",20.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",21.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",23.1,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",23.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",23.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",24,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",24.2,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",24.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",24.5,"P","Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",43.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",46.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",46.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",52.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",54.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",55.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",55.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",55.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",55.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",55.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",54.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",53.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",52.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",52.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",51.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",50.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",49.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",48.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",47.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",47.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",46.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",11.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",12.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",13.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",15.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",16.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",16.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",17.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",18.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",19.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",20.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",22.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",24.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",36.5,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",36,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",32.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",32.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",31.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",30.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",29.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",29.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",30.3,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",30.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",29.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",29.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",29.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",13.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",22.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",18.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",25.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",27.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",23.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",21.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",19.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",19.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",28.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",12,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",13.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",15.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",18.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",23.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",24,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",25.7,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",28.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",32.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",30.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",33.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",35.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",40.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",42.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",45.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",47.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",49,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",51.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",54.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",55.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",57,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",20.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",26.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",25.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",25.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",24.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",23.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",23.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",22.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",30,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",32.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",34.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",36.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",38.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",40.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",41.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",42.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",43.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",43.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",44.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",44.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",44.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",44.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",46.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",45.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",45.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",45.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",47.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",47.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",48.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",50.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",50.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",49.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",47.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",45.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",44.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",43.5,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",41.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",40.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",39.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",38.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",38,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",37.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",40.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",40.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",40.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",40.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",39.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",30.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",17.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",16.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",16.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",16.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",32.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",33.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",35.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",37.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",40.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",41.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",44.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",47.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",52.8,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",53.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",52.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",51.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",50.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",50,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",49,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",48.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",48,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",46.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",44.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",46.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",55.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",53.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",51.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",52.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",53.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",54.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",54.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",55,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",59,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",60.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",62.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",65.3,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",37.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",41.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",48.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",56.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",69.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",78.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",70,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",81.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",75.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",79.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",80.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",80.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",78.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",75.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",75.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",71.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",67.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",64.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",59.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",37.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",39.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",41.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",43.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",46.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",50.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",56.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",62.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",67.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",73.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",78.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",83,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",85.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",87.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",89.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",90,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",88.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",87.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",36.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",39.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",41.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",44.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",48.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",52.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",54.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",58.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",62.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",65.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",69.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",71.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",74.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",76.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",78.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",80,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",80.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",81.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",83.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",36.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",38,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",39.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",40.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",42.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",44.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",48.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",52.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",52.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",52,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",45.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",48.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",47.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",51.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",49,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",54.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",59.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",64.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",69.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",74.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",77.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",78.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",79.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",80.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",81.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",82.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",83.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",84,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",87,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",92.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",52.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",59.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",70.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",66.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",68.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",47.6,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",45.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",45,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",45.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",44.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",44.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",45.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",57.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",61.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",69.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",73.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",75.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",79.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",87.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",85.9,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",82.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",79.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",76.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",75.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",72.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",62.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",54.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",52.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",50.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",49.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",48.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",49.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",26.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",28.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",28.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",30.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",31.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",33.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",33.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",31.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",31.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",36.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",42.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",43.7,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",44.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",46.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",47,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",48.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",50.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",53,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",55.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",58.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",63,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",59.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",58.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",57.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",55.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",55.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",53.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",53.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",53.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",53.3,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",78.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",80.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",71.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",62.1,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",58.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",54,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",51.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",50.1,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",46.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",45.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",43.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",31.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",31.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",33.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",34.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",36.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",38.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",39.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",39.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",39.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",38.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",37.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",36.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",35.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",34,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",33.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",32.7,"D; P","Difference in methodology; Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",33.3,"D; P","Difference in methodology; Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",30.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",31.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",33.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",35.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",36.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",38.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",41.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",43.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",44.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",45.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",47.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",50,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",51.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",53.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",54.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",59.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",60.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",63.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",41.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",43.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",45.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",45.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",46.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",48.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",50.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",52.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",54.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",55.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",55.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",56,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",56,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",57.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",57.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",57.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",58.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",58,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",58.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",61.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",62.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",32.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",33.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",33.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",34.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",36.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",38.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",40.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",44.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",45.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",46.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",45.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",43.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",44.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",45.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",44.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",44.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",44.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",45,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",47.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",47.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",39.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",46,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",55,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",58,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",63.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",68.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",71.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",77.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",79.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",80.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",78,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",76.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",65.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",71.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",70.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",68.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",68,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",65.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",63.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",70,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",35.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",35.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",35.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",35.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",35.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",35.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",36,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",37.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",37.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",37.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",35.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",34.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",35,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",37.2,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",37.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",38.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",38.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",39.4,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",40.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",40.9,"P","Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",29.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",29.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",29.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",34.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",40.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",44,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",47.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",51.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",56.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",62,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",65.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",68.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",71.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",75.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",77.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",79.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",82.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",84.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",87.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",91,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",94.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",18.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",19.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",21.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",23.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",23.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",24.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",23.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",25.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",24.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",25.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",26.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",26,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",57.7,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",62.4,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",67.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",71.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",73.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",76.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",76.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",79.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",80.5,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",82.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",83.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",85.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",87.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",20,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",30.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",31,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",52.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",50.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",42,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",38.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",39.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",35.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",73.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",23.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",31.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",39.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",43.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",53.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",55.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",55.9,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",62,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",69.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",63.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",66.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",64.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",68.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",64.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",61.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",58.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",54.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",52,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",49.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",46.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",46.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",42.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",47.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",45.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",45.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",43.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",40.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",41.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",40.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",48.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",52,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",54.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",56.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",57.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",57.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",59.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",58.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",58.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",57.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",56,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",54.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",80.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",83.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",90.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",95.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",104.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",110.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",119.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",135.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",140,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",139.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",137.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",134.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",134.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",135.5,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",132.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",129.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",126.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",125.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",124.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",123.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",87.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",89.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",89.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",88.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",88.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",87,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",85.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",144,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",142.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",51.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",58.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",69.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",82.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",91.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",98.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",105.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",114.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",132.2,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",143.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",148.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",150.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",151.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",151.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",151.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",149.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",148.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",151.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",175.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",182.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",184.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",185.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",188.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",186.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",182.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",180.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",178.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",206.1,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",207.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",211.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",218.5,"E; D","Estimated value; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",60.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",76.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",86.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",98.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",104.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",134.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",146.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",182.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",188.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",209.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",234.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",233.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",240.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",242.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",248.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",251.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",255,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",255.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",250.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",252.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",45.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",52.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",63,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",74.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",85.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",96.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",109.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",122.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",137.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",148.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",160.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",164.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",171.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",174.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",175.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",177.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",179.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",180.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",65.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",76.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",90.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",107.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",125.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",137.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",150.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",166.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",181.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",194.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",203.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",208.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",215.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",219.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",224.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",229,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",231.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",239.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",252.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",74.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",82.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",91.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",96.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",105.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",116.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",126.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",130.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",141.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",144.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",84.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",105.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",122.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",143.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",144.2,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",168.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",187.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",212.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",241,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",267.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",285.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",297.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",308.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",318.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",329.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",335.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",341.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",342.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",357.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",377,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",92.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",112.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",130.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",137,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",149.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",176.1,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",168.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",171,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",173.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",171.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",169.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",171.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",110.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",119.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",133.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",140.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",150,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",160.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",169.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",272.9,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",284.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",306.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",324,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",334.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",331.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",347.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",359,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",363.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",363.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",365.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",367.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",369.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",384.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",51.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",60.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",67.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",76.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",80.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",89.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",95.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",103.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",109.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",115.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",111.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",117.8,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",118.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",121.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",121.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",124.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",127.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",128.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",133.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",133.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",136.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",217.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",219.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",221.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",222.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",217.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",221.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",219.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",220.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",221.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",221.7,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",36.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",43.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",43.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",45.4,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",45.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",47.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",45.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",43.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",41.7,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",45.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",46.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",48,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",84.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",88.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",90.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",101.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",105.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",111.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",112.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",112.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",109.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",107.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",104.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",102.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",99.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",96.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",95.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",94.9,"D; P","Difference in methodology; Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",92.7,"D; P","Difference in methodology; Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",63.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",70.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",79,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",88,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",95.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",108,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",118.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",126.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",131,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",136.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",140.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",144,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",143.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",143.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",143.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",143.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",143.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",65.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",76,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",87.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",96,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",98.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",106.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",112.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",117.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",124.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",128.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",133.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",136,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",139.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",141.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",143.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",145.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",147.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",150.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",152.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",158.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",160.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",74.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",81.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",87.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",94.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",105,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",113.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",121.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",133.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",141.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",141.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",138.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",127.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",127.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",122.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",119.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",116.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",117.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",115.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",116.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",121.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",122.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",57,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",70.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",81.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",84.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",88.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",105.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",116.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",139.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",151.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",165.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",172.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",178.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",176.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",195.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",198,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",199.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",209.6,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",206.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",205.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",230.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",80.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",88.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",97,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",104,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",113.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",116.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",128.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",137.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",145.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",153.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",158.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",161.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",162,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",162.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",173.8,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",175.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",178.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",179.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",182.7,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",184.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",185.6,"P","Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",42.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",47.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",62.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",77.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",85.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",94.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",106.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",118.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",131.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",140.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",146.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",152.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",157.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",164,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",168.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",173.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",177.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",179.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",182.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",188.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",194.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",56.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",61.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",68.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",71.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",73.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",74.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",75.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",77.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",78.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",82.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",87.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",90.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",153.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",168.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",177.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",185.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",188.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",193,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",195.1,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",197.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",197.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",197.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",197.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",77.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",176,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",140.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",276.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",228.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",215.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",173.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",161.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",231,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",281.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",37.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",48.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",59.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",72,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",94.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",106.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",105.9,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",126,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",151.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",149.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",163.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",165.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",185.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",189.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",191.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",196.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",193.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",198.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",202.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",203.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",210.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",81,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",115.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",111.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",115.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",109.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",107.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",104.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",102.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",217.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",235.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",251.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",259.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",255.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",268.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",262,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",263.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",260.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",258.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",255.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",250.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",247.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",243.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",42.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",51.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",58.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",67.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",80.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",90.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",99.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",110,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",118.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",125.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",131.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",137.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",135.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",134.2,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",131.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",134,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",133.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",134.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",138.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",140.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",57.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",62.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",65.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",69.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",72.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",75.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",80.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",87.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",93.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",101.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",40.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",45.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",48.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",54.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",62.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",68.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",77.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",86.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",101,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",109.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",116.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",121.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",127.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",130.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",130.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",133.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",136.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",137.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",141.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",147.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",64,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",71.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",80.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",87.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",92.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",96.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",98.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",100.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",103.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",117.4,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",121.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",130.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",141.7,"E; D","Estimated value; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",23.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",28.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",32.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",36.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",42.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",56.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",54.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",69,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",67,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",76.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",86.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",92,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",100.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",103.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",112.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",117.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",125.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",130.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",135.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",145.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",9.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",11.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",15.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",24.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",35.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",47.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",61.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",76,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",91.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",99.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",108.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",114.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",120,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",125.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",132.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",141.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",141.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",148.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",18.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",24.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",28.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",36.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",46.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",55.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",62,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",72.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",83,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",91.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",98.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",95.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",98.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",102.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",102.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",105.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",105.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",112.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",121.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",60.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",64.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",66.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",71.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",74.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",82.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",84.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",84.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",88.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",91.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",21.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",25.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",26,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",30.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",32.8,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",36.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",42.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",49.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",56.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",62.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",65,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",67.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",70.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",73,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",76.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",79.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",84,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",87.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",94.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",103.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",102.9,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",99,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",104.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",116,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",123.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",131,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",141.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",31.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",52.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",70.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",91.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",102.5,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",125.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",98.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",90.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",98,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",101.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",104.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",104.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",107.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",108.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",109,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",110.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",111.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",118.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",34.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",44.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",52.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",64.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",75.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",88.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",97,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",112.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",127.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",89.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",71.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",78.8,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",81.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",87.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",87,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",89.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",90.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",91.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",92.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",94.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",97.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",68.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",73.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",76.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",79,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",81.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",85,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",88.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",92.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",97.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",101.7,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",34.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",27,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",30.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",35,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",39.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",45,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",52.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",58.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",63.1,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",67.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",72.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",75.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",113.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",119,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",85.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",94,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",103.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",111.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",116.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",116.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",116.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",117.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",113.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",107.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",104.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",102.2,"D; P","Difference in methodology; Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",101,"D; P","Difference in methodology; Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",57.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",67,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",78.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",92.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",60.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",72.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",79.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",82.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",88.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",94.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",100.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",106.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",111.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",116.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",120.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",124.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",129.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",133.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",136.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",32.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",38.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",45.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",52.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",58.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",68.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",76.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",86.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",97.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",104.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",112.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",116.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",118.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",121,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",123.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",128.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",131.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",135.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",142.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",147.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",161.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",18.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",21.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",26.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",33.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",43.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",52.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",60.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",70.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",78.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",87.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",89.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",87.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",94,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",101.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",105.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",106.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",109.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",108.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",112.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",124.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",134,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",14.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",18.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",24.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",30,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",35.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",43.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",53.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",69.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",77.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",97.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",113.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",129.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",130.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",152.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",152.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",152,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",97.5,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",98.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",93.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",106.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",28.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",34.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",42,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",52.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",64.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",74.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",87.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",101.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",66.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",74,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",82.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",89.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",93.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",96.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",105.4,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",110.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",114.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",117.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",123.2,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",125.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",128.2,"P","Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",18.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",23.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",29.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",34.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",39.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",44.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",50.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",57.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",64.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",71.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",77.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",79.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",85.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",92,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",99.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",106.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",115.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",124.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",134.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",144.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",18.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",21.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",27.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",30.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",25.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",18.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",18.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",18.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",19.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",21.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",23.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",25.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",100.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",111.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",121.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",127.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",129.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",134.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",134.7,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",136.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",139,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",141.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",149,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",27.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",44.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",51.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",58.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",76.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",72.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",66.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",89.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",114,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",101.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",1.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",2.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",4.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",6.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",10.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",14,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",9.1,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",12.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",17.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",20.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",26.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",32,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",40,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",43.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",47.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",51.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",53.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",58.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",64.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",69.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",80.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",81.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",109.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",112.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",115.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",115,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",115,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",116.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",116,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",48.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",57.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",65,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",74.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",80.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",93.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",101.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",109.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",112.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",118.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",125.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",132.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",137.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",146.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",42.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",47.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",49.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",37.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",34.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",35,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",32.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",33.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",33.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",31.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",31.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",32.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",31.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",29.2,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",29.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",30,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",30.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",33.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",34.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",36,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",35.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",33.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",33.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",34,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",33.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",33.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",103.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",104.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",99.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",93.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",87,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",44.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",69.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",76.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",78.5,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",75.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",71.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",68.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",66.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",64.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",62.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",61.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",60.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",58,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",55.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",54.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",21.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",22.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",22.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",23.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",23.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",24.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",25.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",25.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",25.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",43,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",44.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",44.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",47.1,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",86.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",96.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",102.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",104.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",99.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",109.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",107,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",118.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",116.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",116.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",119,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",116.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",118,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",110.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",108.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",105.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",101.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",99.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",96.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",95,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",109.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",112.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",114.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",110.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",104.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",103.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",103.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",102.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",101.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",101.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",102.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",103.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",101.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",101.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",100.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",99.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",99.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",98.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",130.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",135.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",135.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",128.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",125.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",123.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",129.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",129.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",132.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",133.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",134.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",135.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",131.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",135.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",134,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",133.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",133.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",132.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",134.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",91.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",90.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",88.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",83.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",60.9,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",60.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",59.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",60.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",61,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",61.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",62.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",61,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",60.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",59.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",60.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",60.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",59.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",58,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",59,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",62.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",41.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",46.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",52.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",55.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",59.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",29.7,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",29.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",30.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",35.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",36.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",37.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",53.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",49.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",45.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",45.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",19.2,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",18,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",18.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",18.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",19,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",17.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",19.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",19.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",18.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",19.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",20,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",20.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",21.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",22.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",155.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",162.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",155.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",143,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",144,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",141.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",139.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",135.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",130.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",124.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",130,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",109.1,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",110.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",110.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",109.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",110.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",110.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",109.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",106.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",107.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",107.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",43.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",43.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",43.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",43.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",44.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",43.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",41.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",43.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",44.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",43.3,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",19.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",20.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",25.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",27.1,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",29.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",32.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",35.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",37.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",38.2,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",40.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",44,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",47.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",36.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",34,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",31,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",39.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",40.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",41.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",40,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",37.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",35.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",37.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",34.3,"D; P","Difference in methodology; Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",31,"D; P","Difference in methodology; Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",136.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",134.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",150.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",47.5,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",48.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",51.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",54.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",152,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",152.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",158.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",62.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",63.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",55.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",50.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",50.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",51.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",51.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",52.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",53.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",104.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",108,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",106.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",99.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",97.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",94.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",97.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",95.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",96,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",96.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",98.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",101.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",101,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",103.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",107,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",110.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",116.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",117.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",119,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",122.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",121.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",31.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",34.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",37.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",38.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",42.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",44.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",46.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",48.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",49.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",50.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",49.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",47.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",46.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",46.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",47.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",47.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",49.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",48.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",49.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",54.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",52.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",57.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",64.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",66.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",62.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",61.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",62.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",61.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",66.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",70.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",72.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",71,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",71.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",70.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",78.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",81,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",81,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",59.6,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",58.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",57.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",62.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",30.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",31,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",31.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",32.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",33,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",34.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",36.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",42,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",42.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",41.9,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",44.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",47,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",48.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",50.8,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",62.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",60.2,"P","Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",122.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",121.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",122.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",118.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",111.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",105.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",103.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",103,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",102.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",101.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",101.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",100.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",99.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",99.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",102.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",102.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",103.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",104.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",107.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",112.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",112.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",41.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",40.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",44.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",49.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",50.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",50.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",53,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",56.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",53.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",68.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",69.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",73.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",29.8,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",31,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",31.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",33.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",36.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",41,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",41.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",43.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",46.5,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",47.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",48.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",49.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",51,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",21.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",23.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",22.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",25.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",73.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",30.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",35.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",45.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",40.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",32.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",43.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",49.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",48.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",47.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",51.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",50.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",49.6,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",51.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",53.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",50.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",50.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",52.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",54.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",54.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",54.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",55.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",54.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",54.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",55.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",56.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",56.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",32.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",40.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",42.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",43.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",44.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",45.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",45.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",43.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",100.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",99.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",100,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",92.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",88.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",90.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",93,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",95.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",90.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",74.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",73.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",71.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",71.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",72.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",41.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",45.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",47.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",35.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",31.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",32.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",30,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",29.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",30.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",27.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",27.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",27.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",27.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",27.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",27.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",28,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",28.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",16.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",16.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",16.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",15.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",13.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",11.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",10.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",11.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",11.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",11,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",97.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",98.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",93.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",88.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",81.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",38.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",63.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",70.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",72.3,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",69.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",65.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",62.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",61.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",59.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",57.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",56.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",55.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",53.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",51.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",50.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",12.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",11.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",11,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",10.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",9.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",9.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",9.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",8.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",16.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",16,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",14.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",15.5,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",81.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",90.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",94.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",96,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",89.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",96.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",93.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",100.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",97.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",93.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",93,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",87.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",84.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",76.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",70.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",66.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",61.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",57.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",54.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",52.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",102.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",105.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",106.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",101.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",93.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",91.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",89.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",87.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",86,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",84.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",84,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",83.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",81,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",79.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",77.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",75.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",74.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",73.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",114.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",117.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",115.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",107.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",102.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",97.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",97.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",94.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",94.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",93.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",92.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",91.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",86,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",87.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",84.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",82.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",81.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",80.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",80.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",71.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",68.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",65.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",59.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",48.1,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",46.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",44.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",44.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",42.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",41.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",40.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",38.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",36.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",35.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",34.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",33,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",31.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",31.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",34.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",23.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",26.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",29.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",30.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",31.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",3.7,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",3.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",3.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",3.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",3.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",4.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",54.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",51.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",49.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",44.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",40.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",34.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",34,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",10.4,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",8.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",7.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",7.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",7.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",5.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",3.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",4.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",130.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",135.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",127.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",107.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",102.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",96,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",92.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",87.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",82.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",79.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",81.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",85.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",85.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",84.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",82.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",82.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",80.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",77.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",73.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",73.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",71.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",14,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",13.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",12.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",11.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",10.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",5.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",4.9,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",7.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",6.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",8.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",7.9,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",8.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",9.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",9.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",9.9,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",9.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",9.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",10.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",28.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",24.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",23.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",23.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",15.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",17.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",17.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",17.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",16.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",16.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",16,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",14.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",13.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",12.6,"D; P","Difference in methodology; Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",9.6,"D; P","Difference in methodology; Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",126.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",123,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",121.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",35.9,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",36.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",38.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",106.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",105.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",107,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",36.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",36.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",32.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",27.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",26.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",27.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",26.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",26.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",27.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",98.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",100.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",98.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",89,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",85.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",81.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",82.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",78.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",77.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",76.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",77,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",77.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",76.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",77.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",79.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",82.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",87,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",87.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",87.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",88.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",87.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",13.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",14.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",16.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",16.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",17.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",17.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",17.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",17.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",17.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",17,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",16.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",15.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",15.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",15.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",15.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",15.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",16.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",15.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",68,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",64,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",67,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",62,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",61,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",50.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",47.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",47.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",49.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",46.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",43.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",41.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",37.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",38,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",30.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",28.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",23.7,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",22.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",24,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",15,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",12.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",11.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",10.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",10.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",10.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",10.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",10.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",16.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",13.4,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",14.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",16.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",17.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",18.5,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",19.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",19.4,"P","Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",112.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",110.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",110.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",105.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",97.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",90.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",86.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",85.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",83.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",81.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",80.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",78.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",76.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",75.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",76.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",74.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",73.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",73.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",74.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",77.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",76.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",24.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",22.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",23.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",25,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",24.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",22.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",24.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",25.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",24.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",36.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",19,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",17.8,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",17.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",18.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",19.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",21.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",20.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",21,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",21.4,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",20.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",20.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",20.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",20.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",19.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",19.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",19.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",21.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",64.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",16.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",14.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",11.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",29.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",18.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",38.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",45.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",44.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",42.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",46.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",45.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",39.4,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",40.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",40.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",37.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",36.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",36.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",38.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",36.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",35.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",35,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",33.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",31.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",31.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",32,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",30.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",16.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",17.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",17,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",17.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",18,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",18.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",16.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",79.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",75.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",73.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",64.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",59,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",57.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",46.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",44.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",39.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",36.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",34.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",32.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",31.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",31,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",26.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",27.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",27.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",28.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",30.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",32.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",32.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",32.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",33,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",34,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",36.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",38,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",39.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",40.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",41.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",41.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",41,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",41.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",39.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",38.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",39.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",39.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",34.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",34.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",34.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",34.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",34.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",33.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",25.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",27.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",28.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",29.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",31.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",32,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",33.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",37,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",38,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",39,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",40.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",41.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",42.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",43.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",43.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",43.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",44.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",35.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",35.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",36.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",37,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",38.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",39.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",40.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",40.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",41.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",48.2,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",47.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",47.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",47,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",22,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",25.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",26.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",28.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",29.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",33,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",33.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",40.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",35.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",39.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",42.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",43.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",46.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",49.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",51.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",53.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",55,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",53.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",54.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",24.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",25.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",26.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",26.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",27.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",27.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",28.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",29.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",30.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",31.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",32,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",32.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",33.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",34.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",34.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",35.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",35.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",30.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",33.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",34.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",36.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",37.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",38.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",40.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",42.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",43.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",48.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",47.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",50.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",51.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",53.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",54.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",54.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",53.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",55.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",66.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",66.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",68.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",72.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",61.4,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",64.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",66.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",69.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",71.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",73.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",76.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",78.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",80.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",82.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",85.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",86.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",86.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",86.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",88.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",89,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",42.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",45.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",52.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",50.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",55.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",16,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",15.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",16.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",20.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",22.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",24,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",25,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",16.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",17.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",18,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",18.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",14.9,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",15.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",16,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",16.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",17.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",17.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",18.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",20.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",21.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",22.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",23.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",24.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",25.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",26.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",25.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",26.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",20.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",29.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",29.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",30.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",31.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",32.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",32.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",31.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",38,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",36.9,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",38.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",40.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",41.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",43.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",44.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",44.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",44.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",44.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",38.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",39.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",39.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",39.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",39.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",39.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",39.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",40.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",40.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",39.8,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",18.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",24.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",25.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",35,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",37.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",42.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",40.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",32.9,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",33.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",33.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",35.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",43.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",45.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",46.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",44.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",46.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",46.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",48,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",49.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",51.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",52.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",53.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",53.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",54.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",54.7,"D; P","Difference in methodology; Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",54.1,"D; P","Difference in methodology; Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",18.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",19.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",20.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",21,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",21.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",24.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",23.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",24.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",25,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",25.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",26.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",27.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",27.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",28.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",29.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",30.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",33,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",35.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",37.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",37.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",38.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",39.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",41.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",42.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",43.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",44.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",46.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",47,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",47.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",47.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",48.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",48.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",49.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",49.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",48.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",20.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",21.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",21,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",20.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",21.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",21.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",22.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",24,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",25.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",26.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",27,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",27.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",29.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",31.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",36.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",38.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",39.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",38.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",14.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",16,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",18.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",19.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",20,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",20.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",23.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",25.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",27.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",31.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",31.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",29.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",36.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",47.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",51.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",38.5,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",39,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",38.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",40.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",19,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",20.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",21.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",22.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",24.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",25.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",26.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",27.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",28.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",28.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",32.5,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",35,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",37.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",39.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",46,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",48,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",45.9,"P","Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",33.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",34.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",36.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",37,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",38.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",39.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",40.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",41.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",41.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",42.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",42.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",42.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",43.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",43.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",44.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",44.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",45.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",45,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",45.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",44.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",13.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",14.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",14.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",16.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",19.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",17.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",20.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",19.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",21.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",21.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",24.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",25.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",31.2,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",32.3,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",28.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",29.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",30.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",31.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",31.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",32.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",33.3,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",33.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",33.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",34.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",36.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",19.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",34.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",29.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",36.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",35.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",33.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",47.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",42.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",43.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",63.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",10.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",10.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",11.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",11.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",12.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",13.6,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",15,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",17.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",17.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",19,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",19.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",21.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",23.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",24.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",25.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",26.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",28.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",29.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",30.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",25.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",31.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",32.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",31.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",31.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",31.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",15.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",16.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",16.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",17.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",18.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",21.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",20.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",21.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",22.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",23.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",24.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",25.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",26.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",27.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",22.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",22.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",20.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",19.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",21.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",22,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",21.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",24.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",25.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",24.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",25.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",26.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",25.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",20.6,"B; D","Break; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",21,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",21,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",20.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",20.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",19.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",19.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",24.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",22.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",22.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",22.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",25.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",26.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",28,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",28.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",28.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",27.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",27,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",27.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",27.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",14.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",14.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",14.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",15.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",16.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",16.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",16.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",16.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",16.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",20.2,"B; D","Break; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",19.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",19.4,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",19.2,"E; D","Estimated value; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",18.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",13.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",13.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",14.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",15.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",18.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",19.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",18.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",19.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",21,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",19.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",20.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",19.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",20.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",19.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",18.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",18.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",21.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",22.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",20.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",21.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",19.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",20.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",20.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",21.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",21.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",21,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",23.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",22.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",21.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",17.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",16.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",31.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",31,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",30.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",26.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",25.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",25.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",30.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",29.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",30.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",30.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",29.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",29.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",28.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",29.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",29.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",28.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",28.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",29.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",30.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",29.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2005","2005",31.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2006","2006",38.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2007","2007",40.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2008","2008",42.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2009","2009",41.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2010","2010",39.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2011","2011",37,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2012","2012",33.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",34.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",34.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",38.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2016","2016",40.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",39.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",16.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",18.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",16.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",15.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",20.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",18.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",18.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2004","2004",18.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2005","2005",18.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2006","2006",20.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2007","2007",20.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2008","2008",20.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2009","2009",19.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2010","2010",19.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2011","2011",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2012","2012",21.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2013","2013",21.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2014","2014",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2015","2015",23.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2016","2016",22.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2017","2017",21,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2018","2018",22.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2019","2019",22.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2005","2005",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2007","2007",25.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2008","2008",26.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2010","2010",28.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",28.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",29.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",27.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",27.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",27.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",24.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",24.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",24.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",32.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",33.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",34.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",36.9,"B","Break"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",38.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",40.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",39.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",39,"B","Break"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",38.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",34.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",26.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",23.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",24.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",25.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",30,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",29.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",28.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",27.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",26.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",26.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",25.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",25.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2000","2000",9.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",9.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",9.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",13.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",13.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",13.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",13.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",12.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",13,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",12.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",12.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",12.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",12.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",16.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",16.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",16.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",17.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",16.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",17.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",18.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",19.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",18.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",18.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",18.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",17.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",17.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",17,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2000","2000",22.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2001","2001",23.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2002","2002",19.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2014","2014",23.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2015","2015",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2016","2016",28,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2017","2017",29.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2018","2018",28.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2019","2019",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",25.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",24.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",25.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",25.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",23.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",23.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",25.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",24.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",25.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",22.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",24.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",24.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",24,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",24.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",22.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",27.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",26.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",21.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",23.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",20.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",28.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",25.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",16.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",16.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",18,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",16.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",17.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",17.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",15,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",14.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",14.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",36.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",38.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",40.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",43.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",43.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",42.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",41,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",41.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",42.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",37.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",33.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",34.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",20.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",18.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",15.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",21.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",19.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",27.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",26.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",14.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",12.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",12,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",11.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",13.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",13.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",15.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",17.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",17.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",18.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",16.4,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",24.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",27.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",26.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",24.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",20.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",20.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",16.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2000","2000",17.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2001","2001",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2002","2002",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2003","2003",16.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2004","2004",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2005","2005",15.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",14.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",15.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",14.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",14.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",13.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",21.5,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",21.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",19.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",19.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",20.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",21.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",21,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",23.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",24.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",23.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",24.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",24.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",23.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",18.5,"B; D","Break; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",18.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",18.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",18.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",17.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",17.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",17.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",22.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",22.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",22.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",21.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",22.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",22.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",23.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",25.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",24,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",22.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",21.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",13.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",13.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",13.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",14,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",14.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",15.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",15.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",14.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",14.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",17.8,"B; D","Break; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",17.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",17,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",16.7,"E; D","Estimated value; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",13.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",14.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",14.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",15.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",16.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",17,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",17.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",17,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",16.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",21.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",22.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",21.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",19.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",20.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",19.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",19.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",20.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",19.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",19.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",18.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",15.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",14.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",31.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",31,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",30.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",26.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",26.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",25.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",26.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",25.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",25.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",25.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",28.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",28.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",29.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",30.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2005","2005",31.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2006","2006",36.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2007","2007",38.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2008","2008",40.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2009","2009",37.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2010","2010",35.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2011","2011",33.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2012","2012",29.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",31,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",33.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2016","2016",33.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",34.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",34.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",17.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",16.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",18.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",17.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",18.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",16.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",15,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",14.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",14.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",15.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",14.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",14.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",20.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",20.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",18.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",20.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",17.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2004","2004",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2005","2005",18.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2006","2006",20.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2007","2007",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2008","2008",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2009","2009",19,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2010","2010",19,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2011","2011",20.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2012","2012",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2013","2013",21.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2014","2014",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2015","2015",23,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2016","2016",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2017","2017",20.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2018","2018",22.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2019","2019",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2005","2005",22.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2007","2007",24.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2008","2008",25.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2010","2010",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",24.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",24.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",24.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",24,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",20.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",21.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",21.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2011","2011",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2012","2012",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2013","2013",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",26.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",26.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",29.1,"B","Break"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",30.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",31.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",31.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",30.3,"B","Break"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",29,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",26.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",26.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",26.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",26.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",27.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",23.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",24.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",23.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",25.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",23.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",23.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",22.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",22.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",22.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",21.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2000","2000",9.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",9.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",9.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",10.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",11,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",10.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",10.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",10.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",10.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",10.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",9.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",9.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",9.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",16.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",16.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",17.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",16,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",16.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",16.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",16.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",17.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",17.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",16.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",16.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2000","2000",22.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2001","2001",23.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2002","2002",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2014","2014",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2015","2015",24.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2016","2016",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2017","2017",25.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2018","2018",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2019","2019",23.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",19.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",20.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",20.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",17.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",18,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",19,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",19.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",19.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",25.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",27.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",24,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",23.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",22.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",23,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",21.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",23.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",23.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",19.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",26.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",26.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",16.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",15.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",16.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",16.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",15.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",15.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",14.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",13.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",12.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",12.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",35.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",37.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",39.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",42.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",42.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",41.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",39.5,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",40.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",40.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",35.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",31,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",31.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",20.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",20.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",18.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",17.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",18.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",23.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",12.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",11.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",12.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",12.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",11.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",12.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",12.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",11.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",12.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",11.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",15.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",22.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",24.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",23.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",21.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",19.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",13.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2003","2003",9.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2004","2004",9.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2005","2005",9.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2006","2006",9.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2007","2007",10.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2008","2008",10,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","RUS","Russia","2009","2009",12.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2000","2000",17.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2001","2001",16.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2002","2002",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2003","2003",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2004","2004",15.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2005","2005",15.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",15,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",14.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",13.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",13,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",13,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",53,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",61,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",60.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",62,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",53.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",51.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",49.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",43.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",40.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",40.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",61.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",66.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",41.4,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",42.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",43.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",44.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",46,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",48.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",49.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",54,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",52.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",51.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",52.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",52,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",50.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",49.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",49.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",45.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",44.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",47.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",46.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",51.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",55.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",58.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",55.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",55,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",56.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",61.8,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",62,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",61.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",61.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",62.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",62.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",63.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",64.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",64.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",63,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",62.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",60.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",36.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",35.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",34.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",35.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",34.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",31.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",30,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",30.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",27.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",40.8,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",39.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",37.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",38.3,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",63.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",67.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",70.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",74.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",72.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",77.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",71.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",81.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",78,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",78,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",77.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",77.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",78.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",78.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",81.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",81.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",82.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",82.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",84.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",83,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",37.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",40.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",45.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",49.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",68.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",66.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",67,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",67.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",69.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",70.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",72.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",75.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",65.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",65.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",64.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",65.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",64.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",61.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",73.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",78.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",80,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",86.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",93.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",96.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",89.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",97.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",106.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",104.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",101.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",103.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",104.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",100.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",99,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",99.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",98.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",96.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",97.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",55.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",60.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",62.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",66.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",59.3,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",60.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",60.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",64.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",67.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",69.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",70.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",70.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",71,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",71.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",71.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",71.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",70.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",68.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",66,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",66.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",55.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",56.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",60,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",65.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",73.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",41.5,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",38.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",38,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",38.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",40,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",38.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",39.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",54,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",55.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",60.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",65.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",70.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",72.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",74.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",73.9,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",72.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",68.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",60,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",58.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",57.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",58.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",61,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",63.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",56.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",61,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",68.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",78.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",85.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",79.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",79.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",78.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",83.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",85.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",89.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",58.9,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",55.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",53,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",51.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",52.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",53.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",54.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",52.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",52.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",57.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",46.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",44.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",44.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",44.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",43.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",42.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",42,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",42,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",42.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",40.6,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",44.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",67.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",56.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",60.3,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",62.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",65.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",68.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",71.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",67.5,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",69.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",73.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",78.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",74.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",78.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",78.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",73,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",79.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",78.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",76.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",75.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",75.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",77,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",77.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",75,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",75.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",72.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",70.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",67.3,"D; P","Difference in methodology; Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",59.6,"D; P","Difference in methodology; Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",40.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",41,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",43.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",42,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",40,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",38.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",40,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",40,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",39,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",39.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",39.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",39.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",41,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",42.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",42.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",41.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",41.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",40.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",39.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",42.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",50,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",57.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",60.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",65.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",59.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",60.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",61.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",60.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",59.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",59.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",60.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",62,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",62.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",61.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",62.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",62.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",63.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",62.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",63.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",65,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",75.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",82,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",83.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",87.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",95.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",95.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",100.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",104.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",105.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",109.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",105.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",100.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",101.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",101.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",99,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",98.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",97.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",94,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",94.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",93.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",84.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",123.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",134,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",147,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",138,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",123,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",143.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",133.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",143.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",149.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",142.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",140.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",138.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",131,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",139.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",145,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",143.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",71.5,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",73,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",73,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",79.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",66.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",69.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",75.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",80.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",84.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",88.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",87.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",85.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",76.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",70.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",70.1,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",65.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",64.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",68.4,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",70.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",66.4,"P","Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",44.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",47.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",51.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",57.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",61.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",63,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",64,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",66.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",68.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",68.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",67.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",67.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",67.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",66.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",65.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",67.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",70.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",71,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",70.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",72.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",68.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",52.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",53.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",56.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",59.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",63.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",56.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",59.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",64.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",62,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",64.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",54.8,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",54.7,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",48,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",49.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",49.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",50.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",49.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",49.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",49.8,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",49.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",48,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",46.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",43.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",22.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",31.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",32.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",36.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",41.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",37.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",34.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",39,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",42.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",61.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",43.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",40.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",41.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",40.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",44.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",46.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",52.7,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",54.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",58.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",55.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",60.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",63.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",70.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",73.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",76.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",79,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",79.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",80.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",80.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",84.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",84.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",22,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",27.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",27.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",27.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",28.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",28,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",28.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",26.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",61.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",64.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",65.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",62,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",56.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",64.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",58.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",58.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",57.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",61,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",60.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",61.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",64.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",65.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",40.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",47.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",44,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",43.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",41.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",31.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",29.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",30.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",25.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",23.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",22.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",22.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",22.7,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",22.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",22,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",21.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",20.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",20.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",19.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",35.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",35.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",34.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",35.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",33.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",32.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",31.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",31.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",27.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",26.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",36,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",33.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",38.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",39.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",40.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",36.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",34.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",35.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",38.3,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",38.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",38.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",39.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",37.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",37.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",37.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",37.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",35.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",34.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",33.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",19.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",19.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",19.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",21.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",20.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",18.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",17.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",18.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",15.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",22.4,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",20.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",19.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",18.5,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",55,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",58.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",60.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",64,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",61.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",64.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",57.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",64.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",60.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",58.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",57,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",57.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",58.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",57.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",58.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",57.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",58.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",57.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",58.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",56,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",31.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",34.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",38.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",41.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",59.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",54.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",53.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",52.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",52.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",52.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",53.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",54.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",44.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",42.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",40.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",40.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",38.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",36,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",61.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",65.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",65.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",70,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",75.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",77.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",68.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",76.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",85.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",84,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",83.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",84.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",85.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",80.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",79,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",78.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",78.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",76.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",77.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",46.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",54.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",55,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",56.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",55.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",51,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",51.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",53.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",53.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",54.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",30.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",32.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",34.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",34.1,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",33.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",33.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",35.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",37.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",38.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",39.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",40,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",40.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",40.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",39.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",39,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",36.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",36.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",36.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",48,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",46.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",49.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",52.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",57.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",12,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",10.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",10.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",9.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",8.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",7.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",34.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",34.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",39,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",41.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",43.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",44.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",46.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",41.3,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",41.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",37,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",27.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",25.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",24.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",24.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",26.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",26.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",26.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",27.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",27,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",51.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",55,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",61.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",69.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",74.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",68,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",69,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",66.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",73,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",73.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",75.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",45.1,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",38.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",38.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",39.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",39.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",38.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",39.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",41.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",25.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",24,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",23.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",22.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",21.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",20,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",19.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",18.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",18.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",16.5,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",33.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",54.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",37.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",39.8,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",41,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",46.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",49,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",45.5,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",46.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",49.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",50.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",52.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",56.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",59.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",63.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",59.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",51.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",51.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",47.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",51.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",51,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",50.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",51.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",50.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",49.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",48.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",47.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",45.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",44.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",42.3,"D; P","Difference in methodology; Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",35.6,"D; P","Difference in methodology; Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",30,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",30.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",31.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",31.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",27.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",24.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",24.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",24,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",22.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",22.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",22.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",22.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",21.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",20.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",20.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",19.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",19.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",18.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",18.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",32.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",33.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",40.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",45.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",48.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",51.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",44,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",45.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",46.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",46.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",46,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",46.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",47.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",47,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",46.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",47.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",47.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",48.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",47.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",48,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",49.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",63.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",69.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",69.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",69.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",73,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",71.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",73.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",74.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",73.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",76.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",74,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",70.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",71.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",73.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",73,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",73.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",73.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",70.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",71.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",70.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",62,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",41.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",48.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",54.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",49,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",50,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",64.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",52.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",59.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",59.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",58,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",63.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",57.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",53.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",60.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",62.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",60.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",44.2,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",43,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",42.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",44.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",40.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",44.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",44.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",48.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",50.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",51,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",54.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",57.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",58.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",60.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",59.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",58.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",52.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",49.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",49.7,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",45.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",44.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",42.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",42.4,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",44.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",41.3,"P","Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",36.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",39.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",42.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",47.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",50.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",51.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",51.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",53.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",55.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",55.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",54.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",54,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",54.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",53.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",52.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",54.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",56.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",56.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",55.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",56.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",51.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",44.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",45,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",47.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",51,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",54.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",47.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",51.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",53.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",55.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",52,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",51.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",54.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",33.5,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",31.4,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",30.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",30.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",29.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",29.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",28.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",27.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",28.6,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",27.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",27.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",26,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",24,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",20,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",28.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",30.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",33.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",39,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",35.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",32.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",36.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",38.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",56.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",42.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",39.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",40.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",39.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",42.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",43.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",49.4,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",50.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",52.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",48.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",52.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",56.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",61.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",64.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",67,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",68.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",68.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",68.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",67.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",68.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",69.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",10.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",12.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",12,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",12.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",13.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",13.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",12.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",11.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",45.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",45.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",45.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",44.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",43.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",44,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",40.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",39.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",41,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",44.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",43.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",43.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",45.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",46.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",109.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",118.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",121,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",125,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",132.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",138,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",145,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",155.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",163,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",166.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",170.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",184.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",187,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",190.4,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",198.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",204.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",180.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",181.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",185,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",187.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",118.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",123.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",125.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",127.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",130.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",129.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",129.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",133.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",135,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",136.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",69.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",74.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",80,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",86,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",92.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",95,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",99.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",104.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",115.1,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",119,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",123.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",128,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",130.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",133.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",137.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",142.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",146.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",147.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",148.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",153,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",139,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",141.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",146.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",153.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",161.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",164.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",165.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",167.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",170,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",224.9,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",225.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",229.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",236.9,"E; D","Estimated value; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",107.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",112.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",113.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",117.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",119.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",135.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",127.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",143.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",138.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",140.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",143.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",146.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",147,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",151,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",159.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",166.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",169.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",176.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",176.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",182.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",213,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",222,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",229.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",237.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",244.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",251,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",255.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",263.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",267.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",267.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",273.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",277.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",278.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",271.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",262.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",267.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",268.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",267.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",176.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",188.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",199,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",210.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",216.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",226.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",234.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",248.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",256.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",259,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",260.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",267,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",267.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",266.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",264.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",259.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",256.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",261.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",270.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",93.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",96.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",97.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",98.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",84.5,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",91.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",94.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",101.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",108.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",115.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",121.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",125.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",128.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",129.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",133.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",135.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",136.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",136,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",139.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",143.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",144.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",154.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",156.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",165.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",174.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",122.3,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",121.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",128.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",143.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",149.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",157.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",172,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",170,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",176.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",183.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",186.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",185.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",187.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",194.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",136.3,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",137.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",128.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",118.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",123.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",120.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",126.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",124.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",125.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",125.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",125.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",124.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",123.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",125.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",238.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",249.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",263,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",272.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",284.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",298,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",298.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",308,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",309.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",315.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",327.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",286.3,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",288.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",300.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",300.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",314.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",329.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",335.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",331.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",338.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",361.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",79.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",81.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",84.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",85.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",86.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",87.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",86.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",89.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",92.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",94.2,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",65.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",68.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",70.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",84,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",88.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",96.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",101.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",105.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",96,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",100.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",105.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",114.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",188.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",191.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",190.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",195,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",201.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",211.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",215.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",216,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",214.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",214.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",215.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",210.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",208.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",202.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",197.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",193.3,"D; P","Difference in methodology; Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",190.2,"D; P","Difference in methodology; Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",109.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",113.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",118.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",115.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",116.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",109.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",116.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",118.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",92.4,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",98,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",102.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",105.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",103.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",106,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",109.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",111.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",113.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",115.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",109.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",161.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",171.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",182.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",191.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",196.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",204.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",212.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",221.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",226.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",230.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",230.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",233.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",233.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",235.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",237.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",239.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",241.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",243.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",242.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",251.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",256.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",189.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",198.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",202.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",196.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",209.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",219.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",230.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",253.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",265.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",272.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",277.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",277.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",292.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",299.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",306.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",312.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",317.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",321.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",326.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",344.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",351.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",105.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",112.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",122.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",123.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",146,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",148.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",131.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",142.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",152.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",162.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",163.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",165.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",160.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",185.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",196.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",204.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",163.8,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",163.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",168.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",194.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",167.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",171.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",183.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",196,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",207.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",216.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",226.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",232.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",231.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",234.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",254.7,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",269.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",269.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",274.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",300.2,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",309.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",318.1,"P","Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",198.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",210.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",217.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",231.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",237.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",243.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",250.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",257,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",263.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",263.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",269.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",276.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",279.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",286.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",287.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",293.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",299,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",304.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",303.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",314.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",323.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",58.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",62.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",68.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",77.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",79.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",79.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",86.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",91.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",93.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",98.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",101.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",101.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",128.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",135.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",143.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",152.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",159.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",166.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",186.6,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",194.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",201.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",208.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",216.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",89.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",123.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",126.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",123.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",136.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",120,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",111.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",112.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",146.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",196,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",72.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",61.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",60.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",61.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",68.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",71.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",80,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",86,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",87.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",85.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",86.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",91.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",99.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",103.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",108.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",113.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",117.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",123.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",127.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",134.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",142.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",90.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",121.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",125.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",131.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",139,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",143.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",148.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",148.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",104.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",113.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",119.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",123.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",124.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",136.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",132.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",140.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",142.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",145.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",148.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",150.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",152.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",154,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",15.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",16,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",17.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",17.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",18.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",21.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",23.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",25.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",28.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",30.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",34.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",38.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",40.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",42.4,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",43.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",45.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",18.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",17.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",17.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",16.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",10.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",10.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",11,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",11.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",11.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",11.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",12.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",12.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",13.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",14.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",7.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",8.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",9.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",10.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",10.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",11.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",12.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",13.3,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",13.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",14.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",15.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",17.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",18.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",19.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",20.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",21.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",22.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",22.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",23.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",8.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",9.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",9.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",9.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",9.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",9.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",9.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",9.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",9.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",15.7,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",14.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",13.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",14.6,"E; D","Estimated value; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",21.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",21.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",20.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",22.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",20.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",23,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",21.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",23.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",22.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",22,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",21.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",22.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",21.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",21.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",22.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",23.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",24.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",25.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",26.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",25.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",86.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",86.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",87.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",88.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",90.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",92.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",93.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",96.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",96.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",97.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",97.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",97.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",90,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",94.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",96.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",96.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",24.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",27.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",28.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",31.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",32.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",37.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",35.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",40.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",43.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",46.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",47.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",48.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",50.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",50.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",52.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",51.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",53.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",54.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",54.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",17.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",17.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",18.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",19.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",15.9,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",17.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",18.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",20.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",21.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",23.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",23.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",23.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",24.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",24.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",24.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",25,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",25.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",25.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",26.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",27.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",31.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",30,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",29.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",29.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",29.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",4.3,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",4.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",1.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",1.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",1.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",1.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",25.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",24.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",24.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",26.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",23.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",22.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",21.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",6.4,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",6.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",6.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",6.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",6.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",7.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",8.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",8.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",45.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",46.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",46.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",45.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",46.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",49.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",49,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",51.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",52,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",53.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",54.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",32.8,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",32.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",34.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",35.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",37.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",37.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",34.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",5.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",5.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",6.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",6.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",7.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",8.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",8.6,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",15.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",12,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",11.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",11.7,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",12.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",12.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",11.9,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",11.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",12.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",12.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2000","2000",9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2001","2001",9.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2002","2002",11.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",13.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",15.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",17.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",18.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",16.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",19.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",30.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",30,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",31.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",32.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",33.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",33,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",33.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",33.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",32.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",33,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",30.5,"D; P","Difference in methodology; Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",29.3,"D; P","Difference in methodology; Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",12.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",14,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",15.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",9.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",9.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",10.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",11.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",11.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",12.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",13.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",14.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",16.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",12.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",13,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",14.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",14.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",15.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",16.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",9.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",45.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",46.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",48.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",49.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",50,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",52.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",54.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",55.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",57.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",58.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",58,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",59.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",60.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",61.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",63,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",64,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",66,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",67.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",68.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",71.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",73.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",12.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",12.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",13.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",12.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",12.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",16.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",15.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",17.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",17.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",19.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",18.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",18.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",18.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",18.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",19.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",20.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",20.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",20.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",20.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",21.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",24.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",24.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",24.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",24.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",27.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",30.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",40.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",24.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",26.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",28.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",29.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",30.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",32.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",32.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",38.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",40,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",42.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",21.2,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",20.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",22.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",24.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",24.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",25.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",29.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",32.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",35,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",36.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",35.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",37,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",40.7,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",43.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",46.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",49.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",53,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",56.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",60.6,"P","Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",70.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",71.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",72.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",72.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",72.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",73.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",74.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",75.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",77.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",75.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",74.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",74.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",76.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",75,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",74.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",74.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",73.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",68.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",69,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",70.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",7.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",7.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",6.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",7.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",7.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",10.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",9.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",10.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",10.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",10,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",10,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",26,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",28.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",30.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",32.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",35.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",43.4,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",44.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",43.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",43.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",41.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",14.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",22.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",28.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",16.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",27.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",30,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",23.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",20.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",32.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",38.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",14.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",10.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",10.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",10.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",11.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",11.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",12.6,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",13.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",13.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",13.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",12.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",13.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",14.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",15.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",16.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",17.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",18.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",20.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",22.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",23.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",26.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",6.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",7.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",10.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",12.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",12.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",10.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",14.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",14.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",15.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",16.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",17.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",16.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",19,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",16.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",18.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",18.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",20.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",21.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",22.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",22.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",23.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",14.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",13.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",13.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",13.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",14.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",14.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",14.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",15.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",15.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",15.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",15.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",15.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",13.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",11.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",10.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",9.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",9.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",8.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",7.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",7.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",8.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",8.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",8.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",7.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",7.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",7.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",13,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",12.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",12.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",12.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",12.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",12,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",11.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",10.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",10,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",10.9,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",9.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",8.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",8.2,"E; D","Estimated value; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",20.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",19.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",19.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",19.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",18.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",19.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",17.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",18.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",16.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",16,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",15.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",14.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",13.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",12.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",12.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",11.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",11.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",11.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",22.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",22.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",22.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",21.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",21,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",19.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",18.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",17.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",15.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",13.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",10.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",10.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",9.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",7.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",6.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",30.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",31,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",31.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",32,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",31.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",31.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",30.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",30.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",30.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",29.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",27.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",26.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",25.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",24.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",23,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",21.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",20,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",18.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",17.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",60.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",61,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",60.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",57.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",56.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",55.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",54.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",54,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",52.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",52.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",8.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",7.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",6.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",6,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",5.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",5.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",5.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",4.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",4.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",4.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",4.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",3.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",3.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",27.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",28.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",29.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",30.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",31.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",23.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",22.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",23.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",25.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",25.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",27.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",32.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",41.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",43.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",46.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",46.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",48.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",49.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",53.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",24.2,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",23.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",24,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",24.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",26.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",26.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",28.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",28.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",28.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",27.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",27.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",26.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",25.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",25.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",24.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",24.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",27.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",24.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",26.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",25.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",25,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",25.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",24.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",24.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",24.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",22.8,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",21.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",21.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",21.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",21,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",20.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",20.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",19.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",18.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",18.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",1.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",2.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",2.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",1.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",2.1,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",11.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",13.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",13.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",14.9,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",12.4,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",12.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",12.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",48.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",47.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",47.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",47,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",46.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",44.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",42.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",41.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",40.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",36.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",36.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",35.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",33.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",32.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",31.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",30.3,"D; P","Difference in methodology; Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",29.3,"D; P","Difference in methodology; Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",19.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",19,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",19,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",18.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",18.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",15.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",15.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",15.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",5.8,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",6.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",6.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",6.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",7.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",7.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",4.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",19,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",19.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",20,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",20.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",21.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",21.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",21.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",21,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",21,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",20.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",19.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",18.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",17.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",16.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",16,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",14.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",13.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",12.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",78.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",80.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",80.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",79.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",82.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",84.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",87,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",95.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",93.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",93.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",92.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",93,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",96.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",97.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",97.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",97.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",95.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",93.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",92.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",89.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",84.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",19.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",19.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",20.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",18.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",18.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",19.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",20.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",21.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",21.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",22,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",22.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",22.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",21.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",24,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",25.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",24.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",22.1,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",21.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",26.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",38.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",39.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",41.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",42.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",43.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",44.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",46.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",47.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",50.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",51.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",51.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",52,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",51.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",52.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",56.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",56.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",56.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",56.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",56.8,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",56.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",57.9,"P","Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",15.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",15.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",15.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",16.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",16.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",16.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",16.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",16.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",16.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",16.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",16.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",16.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",15.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",15.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",14.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",13.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",12.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",11.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",10.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",2.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",2.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",2.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",2.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",1.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",1.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",5.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",4.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",5.8,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",5.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",5.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",11.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",12.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",10.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",11.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",11.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",10.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",5.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",7.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",8.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",9.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",10.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",12.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",14.4,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",14.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",14.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",13.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",13.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",13.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",14.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",13.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",13,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",13.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",7.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",7.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",7.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",21.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",20.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",19.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",19.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",18.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",18.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",17.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",17.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",16.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",15.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",14.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",13.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",13,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",12.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",11,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",10.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",10.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",10.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",10.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",9.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",9.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",9.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",8.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",7.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",7.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",7.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",6.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",4.7,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",4.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",4.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",3.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",3.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",3.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",4.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",4.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",4.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",4.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",11,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",11.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",11.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",12.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",12.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",11.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",11.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",24.7,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",22.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",21.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",20.9,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",17,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",15.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",15.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",14.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",14.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",15,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",14.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",16.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",16,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",16,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",16.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",16.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",17.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",18,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",19.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",20.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",20.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",21.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",32.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",32.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",32.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",32.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",32.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",31.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",30.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",28.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",26.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",22.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",20.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",19.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",20,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",20,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",19.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",19,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",49,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",51.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",53.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",55.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",55,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",54.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",53.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",53.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",53,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",49.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",48.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",47.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",44.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",42.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",39,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",35.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",31.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",32.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",33.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",9.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",9.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",9.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",8.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",6.7,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",6.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",6.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",6.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",6.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",6.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",6.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",5.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",5.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",5.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",4.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",4.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",17.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",18.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",16.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",14.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",15.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",5.3,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",5.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",6.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",6.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",7.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",9.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",25.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",24.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",24.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",23.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",23.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",22,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",21.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",0.2,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",0.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",0.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",0.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",55.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",55.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",58.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",61.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",64.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",66.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",68.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",69,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",69.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",70.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",73.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",72.3,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",70,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",69.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",66.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",65.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",65.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",64.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",62.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",61.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",66.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",0.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",1.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",1.2,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",5.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",7.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",7.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",8.1,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",8.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",9.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",10.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",10.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",10,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",10.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",11,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",11.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",50.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",51.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",52.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",52.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",52.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",53.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",53.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",54.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",52.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",51.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",49.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",48.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",47.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",45.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",42,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",40.2,"D; P","Difference in methodology; Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",39.7,"D; P","Difference in methodology; Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",22.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",22.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",22.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",22.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",22.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",20.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",21.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",20.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",4.3,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",4.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",5.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",5.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",5.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",5.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",5.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",17.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",31.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",34.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",36.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",37.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",40.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",43.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",45.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",47.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",47.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",48.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",47.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",47.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",45.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",46,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",46.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",45.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",45.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",45.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",44.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",46.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",46.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",20.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",21,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",19.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",17.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",17.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",17.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",18,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",18,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",18.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",18.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",17.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",17.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",18.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",18.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",18.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",17.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",17.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",16.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",16.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",16.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",16.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",15.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",15.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",15.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",14.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",13.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",10.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",10.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",11.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",12.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",14.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",14.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",15.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",14.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",17.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",18,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",18.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",14.4,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",14.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",14.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",16.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",17.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",18.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",19.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",20.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",20.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",21.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",23.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",24.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",24.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",25.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",26.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",27.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",28,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",28.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",30.6,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",30.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",31.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",31.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",32.5,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",32.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",33.9,"P","Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",41.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",44,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",46.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",48.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",49.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",51.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",52.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",52.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",52.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",53,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",53.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",54.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",54.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",54.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",53.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",52.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",54.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",58.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",60.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",65.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",70.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",12.6,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",12,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",12,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",11.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",11.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",11.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",10.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",11.1,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",10.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",10.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",10.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",10.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",4.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",5.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",7.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",7.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",10.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",7.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",8.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",9.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",23.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",36.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",26.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",16.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",13.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",11.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",12.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",12.9,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",14.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",14.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",14.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",14.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",16.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",17.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",18.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",19.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",20.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",21,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",21,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",22.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",15.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",21,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",21.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",22.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",23,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",23.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",24.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",13.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",13.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",14.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",14.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",14.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",14.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",13.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",13.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",12.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",11.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",10.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",10.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",9.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",45.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",53.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",54.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",58.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",63.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",65.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",70.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",76.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",79.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",79.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",80.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",88.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",91.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",96.2,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",100.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",104.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",106.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",109.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",112.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",115.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",54.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",57,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",58,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",59.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",60.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",60.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",60.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",61,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",61.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",62,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",38.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",42,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",45.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",48.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",52.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",53.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",55.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",58.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",64.5,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",66.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",68.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",70,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",70.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",72.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",74.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",77.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",79,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",78.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",79.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",81.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",71.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",71.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",74.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",78.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",82.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",83.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",85,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",87.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",90.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",106.6,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",110.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",114.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",121.5,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",9.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",12,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",14.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",16.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",20.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",26.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",29,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",35,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",35.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",38.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",41.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",44.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",46.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",49,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",52.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",55,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",57.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",59.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",61.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",64.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",35.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",42,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",46.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",52.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",55.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",60.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",64.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",70,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",73.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",78.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",84,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",85.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",83.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",80,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",76.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",77,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",76.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",75.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",35.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",39.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",43.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",45.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",49.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",52.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",55.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",61.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",63.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",66.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",68.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",70.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",69.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",69.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",68.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",68.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",67.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",70.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",74.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2000","2000",39.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2001","2001",42.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2002","2002",45.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2003","2003",46.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2004","2004",49.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2005","2005",49.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2006","2006",48.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2007","2007",50.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2008","2008",50.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2009","2009",49.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",20.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",22.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",24.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",26.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",25.5,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",28.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",30.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",34.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",38.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",41.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",46.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",50,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",51.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",53.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",55.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",56.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",56.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",56.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",58.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",60.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",18.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",23.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",27.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",33.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",35.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",44.7,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",44.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",48.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",55.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",58,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",61,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",65.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",13.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",15.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",17.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",20.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",19.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",22.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",24,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",23.5,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",24.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",25.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",26.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",27.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",26.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",27.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",27.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",28.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",28.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",28.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",29.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",29.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",30.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",70.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",78.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",84.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",90.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",91.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",94.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",92.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",95.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",94.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",98.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",101.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",103.8,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",106.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",113.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",115.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",125.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",133,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",138.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",142,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",146,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",153.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",38.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",38.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",39.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",39.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",39.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",39.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",40.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",41.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",42.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",43,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",7.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",10.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",11.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",13.8,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",15.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",17,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",18,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",20.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",17.2,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",18.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",21,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",23.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",36.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",41.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",42.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",42.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",45.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",47,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",47.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",50.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",51.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",52,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",53.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",56,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",53.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",54.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",53,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",52.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",53.8,"D; P","Difference in methodology; Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",53.9,"D; P","Difference in methodology; Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",31.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",33.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",35.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",38.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",39,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",37.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",39.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",40.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",39.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",40.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",41.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",42.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",43.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",44.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",45.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",45.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",46.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",47.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",47.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2014","2014",72.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",40.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",44.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",48.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",52.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",52.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",51.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",52.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",54.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",55,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",55.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",56.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",57.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",57.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",56.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",57.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",58,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",57.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",57.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",56.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",57.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",58.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",32.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",37.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",41,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",42.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",48.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",51,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",57.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",65.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",72.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",75,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",78.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",78.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",84.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",87.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",92.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",95.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",99.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",103.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",109.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",123.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",131.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",8.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",10.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",13.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",13.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",14.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",18.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",19.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",22.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",24.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",27,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",29,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",30.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",30.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",35.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",38.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",40,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",38.9,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",39.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",41.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",47.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",28.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",31.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",36.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",40.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",44.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",45,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",49.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",52.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",55,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",57.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",61.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",63.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",64,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",65.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",71.3,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",73.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",75.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",77.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",80.4,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",83.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",86.2,"P","Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",44.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",50.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",53.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",62.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",64.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",66.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",69.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",72.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",73.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",74.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",79.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",81.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",84.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",87.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",92.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",95,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",96.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",98.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",102.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",105.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",27.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",29.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",32.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",37,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",37.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",36.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",38.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",40.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",41,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",43.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",44.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",44.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2000","2000",37.6,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2001","2001",42.7,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2002","2002",46.7,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2003","2003",48.8,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2004","2004",50.8,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",47.3,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",52.7,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",53.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",56.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",60.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",65.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",70.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",75,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",82.3,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",87.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",94.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",100.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",107.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",25.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",42.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",41.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",43.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",46.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",36.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",42,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",40.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",52,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",67,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",6.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",7.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",10.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",11.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",12.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",13.7,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",14.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",14.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",14.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",15.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",17.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",20.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",21.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",23.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",24.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",27.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",28.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",31.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",34.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",37.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",34.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",42.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",44.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",46.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",49.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",51.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",53.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",55.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",32.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",37.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",41.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",43.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",44.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",50,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",51,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",53.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",55,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",56.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",58.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",59.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",61.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",63.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",96.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",81.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",74.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",65.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",60.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",55,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",50.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",48.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",46,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",44.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",43.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",43.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",41.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",38.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",38.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",37.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",36.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",35.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",33.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",32.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",39.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",40,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",38.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",37.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",33.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",32.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",30.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",41.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",43.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",41.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",80.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",78.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",80.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",81.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",82.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",85.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",86.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",90.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",98.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",102.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",104.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",108.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",108.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",110.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",111.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",106.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",112.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",108,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",113.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",105.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",30.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",31.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",32.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",33,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",33.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",33.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",33.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",34.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",34.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",57.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",54.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",55.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",56.7,"E; D","Estimated value; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",100.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",114.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",115.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",123.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",134.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",152.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",111.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",124.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",120.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",126.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",131.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",135.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",128.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",131.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",135.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",143.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",146.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",151.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",154.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",154.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",115.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",118,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",119.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",118.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",120,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",119.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",119.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",123.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",123.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",123.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",125.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",127,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",128.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",129.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",132,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",133.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",138.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",142.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",111.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",113.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",117,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",119.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",116.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",124.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",123.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",128.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",135.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",139.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",145,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",145.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",153.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",150.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",165.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",164.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",169.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",174.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",182.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",95.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",91.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",90.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",86.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",67.1,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",69.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",66.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",68.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",69.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",69.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",70,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",68.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",70.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",71,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",70.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",70.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",68.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",71.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",72.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",123.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",135.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",138.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",144.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",155.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",70.7,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",69.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",76.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",74.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",72,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",72.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",68.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",74.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",74.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",74.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",79,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",78.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",82,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",81.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",58.7,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",61,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",62.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",63.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",65.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",62.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",63.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",63.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",64.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",65.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",65.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",66.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",66.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",66.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",101.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",101.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",101.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",104,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",105.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",108.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",107.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",116.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",112.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",112.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",117.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",89.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",90.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",88.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",88,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",91.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",94.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",96.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",94.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",94.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",95.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",53.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",51.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",51.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",51.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",49.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",48.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",43.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",43.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",44.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",45,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",71.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",91,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",81,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",73.7,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",76.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",82.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",84.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",85.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",84.6,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",82.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",86.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",95.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",67.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",70.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",69.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",73.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",68,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",77.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",71.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",71.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",70.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",74,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",74.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",72.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",74.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",69.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",72.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",70,"D; P","Difference in methodology; Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",65.8,"D; P","Difference in methodology; Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",100.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",100.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",98.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",94.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",95.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",94.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",100,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",100.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",101.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",101.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",105.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",106.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",106.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",107.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",108.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",110.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",111.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",111.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",111.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",147.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",151.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",162.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",162,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",163.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",170.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",175,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",180.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",180.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",184.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",184.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",185.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",188.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",188.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",196.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",200.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",205.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",214.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",218,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",231,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",233.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",66.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",68.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",70.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",67,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",67.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",73.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",71.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",83.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",82.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",83.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",81.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",83.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",87.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",87.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",89.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",94.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",98.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",94,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",97.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",100.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",90.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",96.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",99,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",102.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",111,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",133,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",155.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",155.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",180,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",188.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",191.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",193.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",189.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",164.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",193.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",195,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",206.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",132,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",129.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",127.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",140.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",84.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",83.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",84.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",91.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",89.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",93.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",91.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",93.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",82.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",73.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",79.6,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",87.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",86.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",88.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",96.3,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",100,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",101.4,"P","Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",120.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",122.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",130,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",129.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",133.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",136.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",140.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",143.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",144.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",148.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",152.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",154.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",161.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",162.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",170.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",173.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",181.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",190,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",194.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",206,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",215.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",66.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",75.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",75.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",87.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",77.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",82.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",87.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",94.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",96.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",99.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",109,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",111.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",116,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",123.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",131.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",134.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",137.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",145.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",150.1,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",156.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",158.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",165.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",160.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",27.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",39.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",39,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",43.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",48.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",44.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",47.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",48.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",63.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",96.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",68.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",54.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",55.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",59.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",64.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",65.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",55.7,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",60.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",62.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",59.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",61.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",64.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",71.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",75.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",80,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",83.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",85.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",88.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",93.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",93.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",91.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",42.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",50.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",61.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",57.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",60.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",60.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",54.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",56.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",59.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",60.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",61.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",62.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",65.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",64.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",69.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",72,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",73.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",73.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",74.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",76,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2000","2000",84.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2001","2001",75.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2002","2002",67.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2003","2003",58.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2004","2004",53.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2005","2005",48.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2006","2006",44.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2007","2007",42.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2008","2008",40.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2009","2009",38.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",38.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",38.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",37.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",37.4,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",37.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",36.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",35.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",35.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",33,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",31.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",23.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",23.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",22.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",22.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",20.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",19.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",18,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",28.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",31,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",29.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2000","2000",54.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2001","2001",53.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2002","2002",50.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2003","2003",46.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2004","2004",45.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2005","2005",46.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2006","2006",46.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2007","2007",47.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2008","2008",50.3,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2009","2009",51.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",53.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",54.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",54.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",54.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",54.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",53.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",54.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",54.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2007","2007",24.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2008","2008",26,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2009","2009",26.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",27.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",27.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",27.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",28,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",28.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",28.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",37.8,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",36.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",36.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",36.1,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2000","2000",31.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2001","2001",34.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2002","2002",35.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2003","2003",35.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2004","2004",39.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2005","2005",44.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2006","2006",37.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2007","2007",41,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2008","2008",38.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2009","2009",41.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2010","2010",44.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2011","2011",43.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2012","2012",43.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2013","2013",44.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2014","2014",46.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2015","2015",49.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2016","2016",51.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2017","2017",52.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2018","2018",52.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czech Republic","2019","2019",53,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2000","2000",65.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2001","2001",65.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2002","2002",64.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2003","2003",63.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2004","2004",63.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2005","2005",61.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2006","2006",60.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2007","2007",60.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2008","2008",59.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2009","2009",60.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",60.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",60.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",59.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",58.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",58.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",59.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",59.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",60.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2000","2000",49.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2001","2001",49.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2002","2002",49.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2003","2003",51,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2004","2004",50.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2005","2005",51.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2006","2006",54,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2007","2007",54.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2008","2008",56.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2009","2009",58.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",60.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",61.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",62.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",65.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",69.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",72.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",73.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",76.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",78.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2000","2000",50.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2001","2001",47,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2002","2002",46.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2003","2003",46.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2004","2004",43,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2005","2005",44.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2006","2006",44.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2007","2007",46.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2008","2008",45.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2009","2009",47.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",49.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",49.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",49.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",50.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",51,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",49.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",50,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",49.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",51.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",53,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2000","2000",56.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2001","2001",65.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2002","2002",67.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2003","2003",67.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2004","2004",73,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",50,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",50.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",53.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",48.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",48.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",48.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",47.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2000","2000",22.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2001","2001",25,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2002","2002",26,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2003","2003",26.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2004","2004",28.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2005","2005",32,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2006","2006",33.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2007","2007",32.1,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2008","2008",34,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2009","2009",35.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",37.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",39.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",38.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",41,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",42,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",42.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",42.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",41.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",43.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2000","2000",48.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2001","2001",46,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2002","2002",46.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2003","2003",44.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2004","2004",44.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2005","2005",45,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2006","2006",43.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2007","2007",43.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2008","2008",41.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2009","2009",40.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",41.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",43.7,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",40,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",38.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",37.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",41.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",40.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",40.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",40,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",38.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",37.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",33.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",33.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",34.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",33.1,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2008","2008",13.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2009","2009",13.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",19.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",10.3,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",12.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",14.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",15.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",14.3,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",12.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",13.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",13.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2003","2003",20.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2004","2004",24.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2005","2005",24.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2006","2006",24,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2007","2007",24.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2008","2008",18,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2009","2009",24.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",23.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",24.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",24.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",25.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",24.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",23.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",23.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",21.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",21.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",19.7,"D; P","Difference in methodology; Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",18.6,"D; P","Difference in methodology; Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2001","2001",68.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2002","2002",66.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2003","2003",63.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2004","2004",61.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2005","2005",60.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2006","2006",56.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2007","2007",58.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2008","2008",58.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2009","2009",57.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",59,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",60.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",61.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",60.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",60.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",60.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",60.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",60.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",59.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",58.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2000","2000",61.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2001","2001",62.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2002","2002",63.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2003","2003",61.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2004","2004",60.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2005","2005",61.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2006","2006",61.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2007","2007",61.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2008","2008",61.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2009","2009",62.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",63.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",64.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",63.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",63.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",64.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",65.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",66.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",67.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",67.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",68.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",68.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2000","2000",29.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2001","2001",29.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2002","2002",28.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2003","2003",24.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2004","2004",25.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2005","2005",26.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2006","2006",27.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2007","2007",30,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2008","2008",31.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2009","2009",30.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",30.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",31.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",33.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",33.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",34,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",32.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",31.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",31.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",31.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2000","2000",21.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2001","2001",22.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2002","2002",23.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2003","2003",24.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2004","2004",25.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2005","2005",27.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2006","2006",27.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2007","2007",29.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2008","2008",31,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2009","2009",32.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",33.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",34.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",34.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",40.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",41.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",43.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",35.2,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",33.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",31,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",33.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2000","2000",48,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2001","2001",47.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2002","2002",47.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2003","2003",47.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2004","2004",46.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2005","2005",45.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2006","2006",43.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2007","2007",44.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2008","2008",44.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2009","2009",45.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",44.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",46,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",44.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",45.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",47.4,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",53.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",50.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",51.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",57.7,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",58.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",57.9,"P","Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2000","2000",48.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2001","2001",49.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2002","2002",51.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2003","2003",51.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2004","2004",50.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2005","2005",50.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2006","2006",50.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2007","2007",49.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2008","2008",48.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2009","2009",50.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",50,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",50.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",49.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",50.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",52.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",53.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",55,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",55.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",55.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",57.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",61.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2008","2008",17.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2009","2009",19.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2010","2010",22.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2011","2011",24.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2012","2012",24.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2013","2013",29,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2014","2014",32.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2015","2015",37.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2016","2016",38,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2017","2017",40.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2018","2018",43.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Turkey","2019","2019",44.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2005","2005",51.6,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2006","2006",75.7,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2007","2007",81,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2008","2008",84.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2009","2009",88.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",87.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",87.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",90.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",92.8,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",95,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",94.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",97.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",91.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",8.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",10.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",13.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",13.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",16.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",16,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",15.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",15.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",19.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",36.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2000","2000",16.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2001","2001",15.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2002","2002",16.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2003","2003",16,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2004","2004",17.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2005","2005",16.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2006","2006",15.5,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2007","2007",16.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2008","2008",17.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2009","2009",16.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",17.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",18.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",20.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",22.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",23.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",24.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",24.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",25.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",27.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",27.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",28,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",27.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",28.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",25.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",26.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",26.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",27.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",23.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2006","2006",32.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2007","2007",33.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2008","2008",33.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2009","2009",34.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",36.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",36.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",37.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",38.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",39.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",41,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",42.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",42.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",42.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",43.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2006","2006",22.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2007","2007",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2008","2008",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2009","2009",16.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",15.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",17.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",15.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",15.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",16,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",15.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2002","2002",15.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2004","2004",15.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2005","2005",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2006","2006",12.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2007","2007",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2008","2008",12.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2009","2009",11.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2010","2010",12.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2011","2011",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",12.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",13.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",160.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",169.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",182.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",202.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",224.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",259.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",294.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",304.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",360.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",28.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",30.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",33.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",37.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",40.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",42,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",43.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",46.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",52.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",40.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",41.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",42.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",43.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",43.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",45.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",46.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",48.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",50.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",79,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",82.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",82.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",84.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",85.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",88.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",88.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",90.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",92.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",255.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",272.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",279.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",282.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",283.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",297.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",298.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",310.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",333.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",4.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",4.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",7.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",8.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",9.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",9.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",10.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",11.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",12,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",13.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",16,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",18.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",18.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",18.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",18.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",18.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",19,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",19.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",40.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",43.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",46.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",48.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",49.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",52.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",52.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",56,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",60.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",37.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",37.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",37,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",35.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",33.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",33.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",31.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",31.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",33.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",79.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",80.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",79.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",77.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",74.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",74.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",71,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",70.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",72.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",41.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",51.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",56.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",62.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",67.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",79.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",84.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",92.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",101.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",11.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",11.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",12.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",12.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",13,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",13.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",13.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",14.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",15.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",5.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",5.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",4.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",4.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",4.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",20.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",22.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",24,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",24.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",25.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",27.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",31.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2002","2002",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2004","2004",15.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2005","2005",14.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2006","2006",12.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2007","2007",22.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2008","2008",18,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2009","2009",16.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2010","2010",14.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2011","2011",31.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",14.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",15,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",16,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",16.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",17.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",66.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",68.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",71.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",73.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",74.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",75,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",75.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",77.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",79.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",56.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",58.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",61.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",62.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",62.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",62.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",62.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",63,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",63.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",77.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",81.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",84.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",88.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",92.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",97.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",98.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",104.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",112.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",5.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",6.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",6.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",6.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",6.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",6.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",7.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",13.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",15.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",15.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",16.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",6.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",7.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",8.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",8.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",9.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",10.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",9.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",10.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",11.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",12.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",13.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",15,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",16.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",17.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",19.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",48.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",48.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",50.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",49.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",47.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",50.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",50.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",50.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",46.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",9.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",8.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",9.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",7.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",7.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",7.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",6.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",6.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",6.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",184.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",191.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",214,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",217.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",220.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",214.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",213.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",220.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",218.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",231.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",18.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",17.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",19.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",20.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",21.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",21.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",21.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",22.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",23.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",26.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",59.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",66.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",69.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",72.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",71.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",68,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",69.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",74.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",76.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",80.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",14.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",13.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",14.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",14.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",12.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",12.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",12.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",10.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",10.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",9.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",19.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",20.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",23.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",24.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",25.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",27.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",29.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",32.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",35.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",30.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",32.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",37,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",40.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",43.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",44.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",47.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",50,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",53.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",56.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",3.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",2.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",0.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",0.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",0.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",0.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",19,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",18.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",20.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",24.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",24.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",23.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",22.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",22.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",21.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",21.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",53.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",59.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",69.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",72.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",78.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",80.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",83.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",88.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",89.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",89.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",28.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",27.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",30.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",29.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",30.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",29.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",31,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",30.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",35.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",36.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",36.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",37.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",36.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",36.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",32.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",28.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",27.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",26.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",27.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",53.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",60,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",62.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",65.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",64.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",60.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",61.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",64.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",65.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",66.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2006","2006",23.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2007","2007",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2008","2008",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2009","2009",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",16.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",16.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",17.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",17.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",18.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",5.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",6.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",7.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",6.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",7.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",8.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",9.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",9.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",10.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",11.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",118.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",123.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",136.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",140.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",149.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",153.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",155.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",155.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",153.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",161.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",17.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",16.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",16.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",16.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",16.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",15.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",15.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",15.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",14,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",14.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",20.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",21.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",25.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",28.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",29.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",29.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",26.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",26.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",23.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",26.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",357.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",373.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",425.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",438.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",451.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",439.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",439.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",454.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",457.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",492.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",25.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",26.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",31.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",33.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",36.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",39,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",41.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",43.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",44.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",46.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",30.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",34.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",23,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",25.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",26.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",27.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",30.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",32.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",9.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",13.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",15.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",19.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",21.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",29.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",37.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",46.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",58.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",5.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",6.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",6.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",6.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",6.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",7.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",7.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",46.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",51.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",60.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",65.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",71.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",71.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",73.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",75,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",74.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",77.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",55.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",57.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",63.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",69.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",67.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",70.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",69.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",70.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",73.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",74.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",36.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",37.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",40.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",41.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",41.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",41,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",40.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",37.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",33.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",32.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",98.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",103.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",113.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",96.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",103.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",126,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",125.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",129.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",138.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",156.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",25.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",28.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",28.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",32.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",34.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",37.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",38.4,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",42.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",40.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",45.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",46.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",47.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",53.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",58.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",53.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",55,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",56.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",58.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",63.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",66.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",89.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",113.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",142.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",142.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",167.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",190.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",200.1,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",230.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",221.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",250.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",261.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",273.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",307.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",324.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",294.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",301.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",309,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",324.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",339.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",356.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",5.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",7.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",9.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",11.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",13.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",16,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",15.7,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",19.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",19.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",21.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",24.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",26.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",29.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",29.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",28.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",29.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",30.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",33.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",35.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",39,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",20.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",22.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",25.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",27.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",32.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",35.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",37.5,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",43.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",41.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",50,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",57.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",60.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",54.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",54.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",54.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",56.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",57.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",60.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",36.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",46.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",61.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",53.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",64,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",76.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",81.6,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",92.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",91.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",104.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",111,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",115.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",129.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",138,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",126.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",130.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",135.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",144.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",153,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",164,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",19.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",21.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",20.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",21.1,"B","Break"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",23.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",24.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",23.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",25.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",22.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",20.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",13,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",13.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",14,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",9.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",6.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",7.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",7.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",7,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",7.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",6.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",7.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",7.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",6.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",6.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",7.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",18.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",21.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",25.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",19.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",22.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",24.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",24.8,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",27,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",24,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",28,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",29.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",32.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",33.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",31,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",32,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",32.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",33,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",35,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",33.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",6.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",8.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",12.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",15,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",19.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",21.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",24.6,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",30,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",28.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",32.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",34.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",36.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",41.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",43.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",40.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",44.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",47.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",51.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",55,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",56.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",11.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",11.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",11.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",12.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",19.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",14.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",12.7,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",14.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",13.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",15.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",14.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",14.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",16.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",17,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",15.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",16.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",16.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",17.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",19.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",19.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",20.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",24,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",26.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",28.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",32.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",36,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",37.2,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",42.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",40.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",45.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",48,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",50.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",57,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",61.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",57.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",59.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",62.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",66.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",72.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",78.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",2.2,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",22.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",24.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",25.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",26.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",30,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",29.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",31.3,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",32.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",29.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",33.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",31.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",32.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",36.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",38.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",34.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",35.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",36.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",37.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",38.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",50.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",0.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",0.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",0.3,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",10.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",16,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",18.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",21.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",24.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",28.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",28.9,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",34.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",32.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",37,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",39.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",41.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",46.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",49.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",44.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",44.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",44.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",46.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",48.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",50.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",1.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",1.1,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",1.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",1.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",1.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",1.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",2.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",0.9,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",125.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",127.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",167.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",145.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",151,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",150.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",143.2,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",158.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",139.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",146.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",126.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",127.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",136.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",138.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",126.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",126.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",128.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",136.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",145.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",145.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",10.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",16,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",20.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",21.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",21.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",24,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",23.3,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",25.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",23.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",24.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",25,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",25.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",27.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",27.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",24.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",23.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",22.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",21.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",21.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",21.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",27.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",23.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",25.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",25.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",25,"B","Break"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",26.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",24.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",28.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",30,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",31.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",31.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",26.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",24.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",24,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",16.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",8.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",9.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",8.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",9.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",8.9,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",9.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",8.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",9.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",8.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",8.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",9.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",9.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",8.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",8.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",9.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",9.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2001","2001",18.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2002","2002",19.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2003","2003",20.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2004","2004",21.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2005","2005",20.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2006","2006",21.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2007","2007",21.9,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2008","2008",23.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2009","2009",21.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",22.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",23.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",22,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",24.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",25.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",23.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",23,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",22.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",22.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",23.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",21.3,,
